School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Viraj Master MD, PhD, FACS

  • Department of Urology
    Professor
  • (404) 778-4898
Head shot of Viraj Master

Overview

Following his undergraduate education at Northwestern University, Dr. Master received both his MD and PhD degrees at the University of Chicago. He completed his urology residency and two urologic fellowships at the University of California in San Francisco before joining Emory Urology in 2005.

Dr. Master's clinical practice focuses on renal, adrenal, testicular and penile cancer. Having completed fellowships in both reconstructive urology with Dr. Jack McAninch and in oncology with Dr. Peter Carroll, he is committed to penile preserving therapies and minimally invasive approaches to groin and pelvic nodes. Along with other colleagues, he refined videoscopic groin dissection for a variety of cutaneous malignancies, including melanoma, anal, vulvar, and penile cancer. His work in kidney cancer focuses on cancer immunology in the context of locally advanced and metastatic renal cell carcinoma, and he regularly performs inferior vena cava (IVC) tumor thrombectomy.

As the director of clinical research for Emory Urology, Dr. Master is actively investigating both the role of inflammation in cancers and "host" (patient) interaction with the disease.

Dr. Master serves as an expert advisor to the American Cancer Society on prostate cancer and to the International Consultation on Urologic Diseases on kidney cancer. He has lectured both nationally and internationally; is closely involved in teaching and mentoring medical students, urology residents, and post-graduate fellows; and has authored multiple book chapters and scientific journal articles.

In addition to his dedication to Emory patients, Dr. Master is also involved in humanitarian pursuits. He has made several surgical trips to Haiti as a member of the Emory Haiti Alliance, a volunteer consortium of Emory medical students, surgery and anesthesiology residents, faculty physicians, and mid-level practitioners that journey to Haiti in the summer to provide surgical care in the Central Plateau region, the poorest and most medically underserved area in the country.

Academic Appointment

  • Associate Professor of Urology (Clinical Track), Emory University
  • Associate Professor, Winship Cancer Institute, Emory University

Education

Degrees

  • PhD from University of Chicago
  • MD from University of Chicago
  • BA from Northwestern University

Research

Focus

  • Outcomes of high-risk genitourinary cancers, especially in low-socioeconomic strata individuals. Particular interests are the influence of stage at presentation, inflammation, poverty, stress and diet on metastatic disease. Literacy as it affects treatment choices which drive outcomes are an integral focus of this research.

Publications

  • Thromboembolic Events in Castration-Resistant Prostate Cancer Patients With and Without Cardiovascular Comorbidities Receiving Oral Androgen Receptor Pathway Inhibitors.
    Prostate Volume: 85 Page(s): 954 - 965
    07/01/2025 Authors: Asiri IM; Chen RC; Master V; Mi L; James SE; Bryce AH; Afzal U; Riaz IB; Ahmed Naqvi SA; Beach SRH
  • A Spatial Metabolomics Annotation Workflow Leveraging Cyclic Ion Mobility and Machine Learning-Predicted Collision Cross Sections.
    J Am Soc Mass Spectrom Volume: 36 Page(s): 1386 - 1394
    06/04/2025 Authors: Leontyev D; Gier EC; Master VA; Arnold RS; Petros JA; Fernndez FM
  • UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion.
    World J Urol Volume: 43 Page(s): 355
    06/04/2025 Authors: Saitta C; Garofano G; Musso G; Tanaka H; Patil D; Nguyen V; Yuen KL; Baker B; Dabbas M; Meagher MF
  • Incidence of New Mental Health Diagnosis in Testicular Cancer Survivors.
    Urology Volume: 200 Page(s): 135 - 141
    06/01/2025 Authors: Marthi S; Palmateer G; Helman T; Patil D; Nicaise E; Goodstein T; Ogan K; Narayan V; Master V; Joshi SS
  • Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma.
    Clin Genitourin Cancer Volume: 23 Page(s): 102343
    06/01/2025 Authors: Saitta C; Autorino R; Capitanio U; Lughezzani G; Meagher MF; Yim K; Nguyen MV; Mantovani M; Guer M; Amparore D
  • Integrating Botanicals into Oncology Care: Consideration of FDA Regulation of Botanical Products and Botanical Clinical Trials.
    Clin Cancer Res Volume: 31 Page(s): 1566 - 1572
    05/01/2025 Authors: Berman TA; Ben-Arye E; Kienle GS; Master V; Huston A; Paller CJ
  • Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotyping.
    Urol Oncol
    05/01/2025 Authors: Cavanaugh D; Holt SK; Dwyer E; Petersen E; Gore JL; Schade GR; Grivas P; Hsieh AC; Lee JK; Montgomery B
  • Primary penile mesenchymal tumors: A clinicopathologic analysis of 48 cases.
    Hum Pathol Volume: 159 Page(s): 105814
    05/01/2025 Authors: Younes AI; Osunkoya AO; Gandhi JS; Master VA; Bahrami A
  • Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinoma.
    Urol Oncol
    04/21/2025 Authors: Musso G; Meagher MF; Yuen KL; Baker B; Baker O; Ahdoot A; Puri D; Dabbas M; Birouty N; Saitta C
  • Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study.
    Int J Urol Volume: 32 Page(s): 414 - 422
    04/01/2025 Authors: Chen W; Tanaka H; Kobayashi M; Fukuda S; Nakayama A; Meagher MF; Yoshida S; Derweesh IH; Master VA; Hirakawa A
  • A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
    Eur Urol Volume: 87 Page(s): 385 - 389
    04/01/2025 Authors: Bex A; Jewett M; Lewis B; Abel EJ; Albiges L; Berg SA; Bratslavsky G; Braun D; Brugarolas J; Choueiri TK
  • Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients.
    Cancer Epidemiol Volume: 95 Page(s): 102769
    04/01/2025 Authors: Asiri IM; Chen RC; Master V; Mi L; James SE; Odedina FT; Bryce AH; Tilburt JC; Riaz IB; Naqvi SAA
  • Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
    Nat Cancer Volume: 6 Page(s): 432 - 444
    03/01/2025 Authors: Bilen MA; Vo BT; Liu Y; Greenwald R; Davarpanah AH; McGuire D; Shiradkar R; Li L; Midya A; Nazha B
  • Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial.
    Eur Urol Volume: 87 Page(s): 271 - 274
    02/01/2025 Authors: Pal SK; Grivas P; Gupta S; Dizman N; Zengin Z; Valderrama BP; Rodriguez-Vida A; Roghmann F; Sevillano Fernandez E; Matin SF
  • Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
    Clin Genitourin Cancer Volume: 23 Page(s): 102276
    02/01/2025 Authors: Hopkins BD; Qian DC; Xu KM; McCook-Veal A; Switchenko J; Hartsell LM; Cimmino CB; Joshi SS; Narayan V; Master VA
  • Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.
    J Immunother Precis Oncol Volume: 8 Page(s): 1 - 10
    02/01/2025 Authors: Zhuang TZ; Goyal S; Case KB; Olsen TA; Vemuru S; Yildirim A; Goswamy RV; Brown JT; Carthon BC; Kucuk O
  • Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry.
    World J Urol Volume: 43 Page(s): 63
    01/09/2025 Authors: Chen W; Tanaka H; Kobayashi M; Fukuda S; Nakayama A; Meagher MF; Greenwald R; Schmeusser B; Nicase E; Waseda Y
  • Characterizing Psychological Resources and Resilience in Patients With Bladder Cancer: Associations With Frailty and Quality of Life.
    J Urol Volume: 213 Page(s): 40 - 51
    01/01/2025 Authors: Petersen E; Holt S; Browning A; Cavanaugh D; Jannat S; Wright J; Gore J; Schade G; Reed M; Garcia J
  • Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
    Volume: 17 Page(s): 17588359251316243
    01/01/2025 Authors: Yildirim A; Wei M; Liu Y; Nazha B; Brown JT; Carthon BC; Choi Y; Suh L; Goswamy RV; McClintock GR
  • Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life.
    Eur Urol
    12/19/2024 Authors: St-Laurent M-P; Bochner B; Catto J; Davies BJ; Fankhauser CD; Garg T; Hamilton-Reeves J; Master V; Jensen BT; Lauridsen SV
  • Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010.
    Eur Urol Oncol Volume: 7 Page(s): 1175 - 1178
    12/01/2024 Authors: Karam JA; Uzzo R; Bex A; Leung W; Tat C; Nicholas A; Andreev-Drakhlin A; Huseni M; Pal SK; Master VA
  • First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.
    Eur Urol Volume: 86 Page(s): 503 - 512
    12/01/2024 Authors: El Zarif T; Semaan K; Xie W; Eid M; Zarba M; Issa W; Zhang T; Nguyen CB; Alva A; Fahey CC
  • Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma.
    Clin Genitourin Cancer Volume: 22 Page(s): 102207
    12/01/2024 Authors: Nicaise EH; Schmeusser BN; Palmateer G; Vashi K; Parikh K; Patil D; Shapiro DD; Abel EJ; Joshi S; Narayan V
  • Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.
    Nature Volume: 636 Page(s): 224 - 232
    12/01/2024 Authors: Cardenas MA; Prokhnevska N; Sobierajska E; Gregorova P; Medina CB; Valanparambil RM; Greenwald R; DelBalzo L; Bilen MA; Joshi SS
  • NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma.
    Clin Genitourin Cancer Volume: 22 Page(s): 102232
    12/01/2024 Authors: Saitta C; Garofano G; Afari JA; Tanaka H; Patil D; Yuen KL; Wang L; Cortes J; Meagher MF; Puri D
  • PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
    Cancer Volume: 130 Page(s): 3658 - 3670
    11/01/2024 Authors: Martini DJ; Case KB; Gratz D; Pellegrini K; Beagle E; Schneider T; Dababneh M; Nazha B; Brown JT; Joshi SS
  • The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
    Urol Case Rep Volume: 57 Page(s): 102875
    11/01/2024 Authors: Palmateer G; Nicaise EH; Gandhi J; Goodstein T; Sheng M; Ogan K; Kucuk O; Yushak M; Sanda MG; Delman KA
  • Author Correction: Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.
    Nature Volume: 635 Page(s): E9
    11/01/2024 Authors: Cardenas MA; Prokhnevska N; Sobierajska E; Gregorova P; Medina CB; Valanparambil RM; Greenwald R; DelBalzo L; Bilen MA; Joshi SS
  • Multidisciplinary management of chylous ascites following resection of a retroperitoneal, functional Paraganglioma.
    Urol Case Rep Volume: 57 Page(s): 102888
    11/01/2024 Authors: Nicaise EH; Morton E; Croll B; Palmateer G; Patel G; Swilley B; Master VA
  • Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.
    Cancers (Basel) Volume: 16
    10/30/2024 Authors: Palmateer G; Nicaise EH; Goodstein T; Schmeusser BN; Patil D; Imtiaz N; Shapiro DD; Abel EJ; Joshi S; Narayan V
  • Tailoring language for genitourinary function in patients with newly diagnosed prostate cancer to facilitate discussions in diverse populations and overcome health literacy barriers.
    Cancer Volume: 130 Suppl 20 Page(s): 3602 - 3611
    10/15/2024 Authors: Kilbridge KL; Patil D; Filson CP; Shelton JW; Thomson SW; Rosenbaum CH; Rothmann EC; Martin-Doyle W; Trinh Q-D; Narayan VM
  • Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database.
    Volume: 42 Page(s): 333.e21 - 333.e31
    10/01/2024 Authors: Liu F; Wang L; Meagher MF; Afari J; Saitta C; Dhanji S; Ghassemzadeh S; Shah A; Puri D; Nguyen MV
  • A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumorsof the Testis: Implications for Adverse Events and Complications.
    Urology Volume: 192 Page(s): 74 - 82
    10/01/2024 Authors: Buxton C; Schmeusser BN; Holt SK; Patil D; Phuong A; Chahine S; Marquardt JP; O'Malley R; Laidlaw G; Schade GR
  • Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry.
    Clin Genitourin Cancer Volume: 22 Page(s): 102126
    10/01/2024 Authors: Cortes JA; Saitta C; Yuen KL; Patil D; Tanaka H; Puri D; Afari JA; Mahmood M; Matian J; Mansour M
  • [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
    Lancet Oncol Volume: 25 Page(s): 1277 - 1287
    10/01/2024 Authors: Shuch B; Pantuck AJ; Bernhard J-C; Morris MA; Master V; Scott AM; van Praet C; Bailly C; nal B; Aksoy T
  • Recommendations for Healthy Lifestyle for Cancer Prevention and Healthy Aging.
    J Cancer Prev Volume: 29 Page(s): 55 - 57
    09/30/2024 Authors: Kucuk O; Master VA
  • Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.
    Oncologist Volume: 29 Page(s): 738 - 746
    09/06/2024 Authors: Chukkalore D; MacDougall K; Master V; Bilen MA; Nazha B
  • Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma.
    Am J Hum Genet Volume: 111 Page(s): 1864 - 1876
    09/05/2024 Authors: Dutta D; Guo X; Winter TD; Jahagirdar O; Renal Cancer Genetics Consortium; Ha E; Susztak K; Machiela MJ; Chanock SJ; Purdue MP
  • Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and Management.
    Eur Urol Focus
    08/14/2024 Authors: Chahine SY; Alkhatib KY; Arakelyan G; Buxton C; Giannarini G; Hamilton RJ; Holt SK; Bernhard J-C; Jiang DM; Lin D
  • Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.
    Res Sq
    08/08/2024 Authors: Bilen MA; Vo BT; Liu Y; Greenwald R; Davarpanah AH; McGuire D; Shiradkar R; Li L; Nazha B; Brown JT
  • Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
    Lancet Oncol Volume: 25 Page(s): 1038 - 1052
    08/01/2024 Authors: Allaf ME; Kim S-E; Master V; McDermott DF; Harshman LC; Cole SM; Drake CG; Signoretti S; Akgul M; Baniak N
  • Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
    J Natl Cancer Inst Volume: 116 Page(s): 966 - 973
    06/07/2024 Authors: Rose KM; Pham R; Zacharias NM; Ionescu F; Paravathaneni M; Marchetti KA; Sanchez D; Mustasam A; Sandstrom R; Vikram R
  • Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
    Clin Genitourin Cancer Volume: 22 Page(s): 102056
    06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS
  • Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry.
    Clin Genitourin Cancer Volume: 22 Page(s): 102098
    06/01/2024 Authors: Saitta C; Afari JA; Patil D; Tanaka H; Yuen KL; Wang L; Cortes J; Liu F; Mahmood M; Matian J
  • Differences in preoperative frailty assessment of surgical candidates by sex, age, and race.
    Surg Open Sci Volume: 19 Page(s): 172 - 177
    06/01/2024 Authors: Nicaise EH; Palmateer G; Schmeusser BN; Futral C; Liu Y; Goyal S; Nabavizadeh R; Kooby DA; Maithel SK; Sweeney JF
  • Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial.
    Surg Open Sci Volume: 19 Page(s): 205 - 211
    06/01/2024 Authors: House MG; Kim R; Tseng EE; Kaufman RP; Moon MR; Yopp A; Master VA
  • Adherence Patterns and Acceptability of a Perioperative, App-Based Mindfulness Meditation Among Surgical Patients With Chronic Pain.
    Am Surg Volume: 90 Page(s): 936 - 938
    05/01/2024 Authors: Diller ML; Mascaro J; Haack C; Master V
  • Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.
    Nat Genet Volume: 56 Page(s): 809 - 818
    05/01/2024 Authors: Purdue MP; Dutta D; Machiela MJ; Gorman BR; Winter T; Okuhara D; Cleland S; Ferreiro-Iglesias A; Scheet P; Liu A
  • A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila.
    Genetics Volume: 226
    04/03/2024 Authors: Brockett JS; Manalo T; Zein-Sabatto H; Lee J; Fang J; Chu P; Feng H; Patil D; Davidson P; Ogan K
  • A Contemporary Clinicopathologic Analysis of Patients With Renal Cell Carcinoma and Vena Cava Involvement.
    Int J Surg Pathol Volume: 32 Page(s): 279 - 285
    04/01/2024 Authors: Al-Rusan OM; Patil D; Master VA; Osunkoya AO
  • The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.
    Eur Urol Oncol Volume: 7 Page(s): 266 - 274
    04/01/2024 Authors: Abel EJ; Master VA; Spiess PE; Raman JD; Shapiro DD; Sexton WJ; Zemp L; Patil D; Lauer K; Allen GO
  • Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274.
    Eur Urol Oncol Volume: 7 Page(s): 302 - 303
    04/01/2024 Authors: Abel EJ; Master VA; Spiess PE; Raman JD; Shapiro DD; Sexton WJ; Zemp L; Patil D; Lauer K; Allen GO
  • Interruptions in bladder cancer care during the COVID-19 public health emergency.
    Urol Oncol Volume: 42 Page(s): 116.e17 - 116.e21
    04/01/2024 Authors: Gore JL; Follmer K; Reynolds J; Nash M; Anderson CB; Catto JWF; Chamie K; Daneshmand S; Dickstein R; Garg T
  • Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
    Urol Oncol Volume: 42 Page(s): 119.e1 - 119.e16
    04/01/2024 Authors: Saitta C; Afari JA; Walia A; Patil D; Tanaka H; Hakimi K; Wang L; Meagher MF; Liu F; Nguyen MV
  • Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
    J Immunother Cancer Volume: 12
    03/26/2024 Authors: Patel JS; Woo Y; Draper A; Jansen CS; Carlisle JW; Innominato PF; Lvi FA; Dhabaan L; Master VA; Bilen MA
  • 2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race.
    Cancer Volume: 130 Page(s): 453 - 466
    02/01/2024 Authors: Schmeusser BN; Patil DH; Nicaise EH; Armas-Phan M; Nabavizadeh R; Narayan VM; Joshi SS; Ogan K; Osunkoya AO; Bilen MA
  • AUTHOR REPLY.
    Urology Volume: 183 Page(s): 155 - 156
    01/01/2024 Authors: Schmeusser BN; Nicaise EH; Ogan K; Master VA
  • Performance of Future Glomerular Filtration Rate Equation by Race in a Large, Racially Diverse Patient Cohort Undergoing Nephrectomy for Renal Cell Carcinoma.
    Urology Volume: 183 Page(s): 147 - 156
    01/01/2024 Authors: Schmeusser BN; Nicaise EH; Palacios AR; Ali A; Patil DH; Armas-Phan M; Ogan K; Master VA
  • Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
    CA Cancer J Clin Volume: 74 Page(s): 323 - 338
    01/01/2024 Authors: Nicaise EH; Yildirim A; Sheth S; Richter E; Daneshmand MA; Maithel SK; Ogan K; Bilen MA; Master VA
  • The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers.
    Biomark Insights Volume: 19 Page(s): 11772719241254179
    01/01/2024 Authors: Seema Mustafa; Jansen CS; Jani Y; Evans S; Zhuang TZ; Brown J; Nazha B; Master V; Bilen MA
  • Perioperative systemic treatments in renal cell carcinoma.
    Front Oncol Volume: 14 Page(s): 1362172
    01/01/2024 Authors: Goswamy R; Kalemoglu E; Master V; Bilen MA
  • Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
    Cancer Volume: 129 Page(s): 3884 - 3893
    12/15/2023 Authors: Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI
  • Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Oncologist Volume: 28 Page(s): 1072 - 1078
    12/11/2023 Authors: Sanda GE; Shabto JM; Goyal S; Liu Y; Martini DJ; Nazha B; Brown JT; Yantorni LB; Anne Russler G; Caulfield S
  • Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
    Oncologist Volume: 28 Page(s): e1219 - e1229
    12/11/2023 Authors: Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS
  • Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
    J Natl Cancer Inst Volume: 115 Page(s): 1605 - 1615
    12/06/2023 Authors: El Zarif T; Nassar AH; Pond GR; Zhuang TZ; Master V; Nazha B; Niglio S; Simon N; Hahn AW; Pettaway CA
  • Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.
    Eur Urol Oncol Volume: 6 Page(s): 638 - 639
    12/01/2023 Authors: Shapiro DD; Karam JA; Master VA; Sexton WJ; Matin SF; Spiess PE; Abel EJ
  • Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients.
    Urology Volume: 182 Page(s): 168 - 174
    12/01/2023 Authors: Esdaille AR; Karam JA; Master VA; Spiess PE; Raman JD; Sharma P; Shapiro DD; Das A; Sexton WJ; Zemp L
  • Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer.
    BMC Cancer Volume: 23 Page(s): 1127
    11/18/2023 Authors: Gore JL; Wolff EM; Comstock BA; Follmer KM; Nash MG; Basu A; Chisolm S; MacLean DB; Lee JR; Lotan Y
  • Evaluation of a Non-race-based Equation in Predicting Glomerular Filtration Rates Postnephrectomy in a Racially Diverse Cohort.
    Urol Pract Volume: 10 Page(s): 547 - 550
    11/01/2023 Authors: Nicaise EH; Schmeusser BN; Patil DH; Ogan K; Master VA
  • Editorial Comment.
    J Urol Volume: 210 Page(s): 760 - 761
    11/01/2023 Authors: Master VA; Nicaise E
  • Reply by Authors.
    Urol Pract Volume: 10 Page(s): 552
    11/01/2023 Authors: Nicaise EH; Schmeusser BN; Patil DH; Ogan K; Master VA
  • A Contemporary Clinicopathologic Analysis of Primary Sarcomas of the Perinephric Soft Tissue and Hilar Vessels Including a Subset Secondarily Involving the Kidney.
    Int J Surg Pathol Volume: 31 Page(s): 1179 - 1186
    10/01/2023 Authors: Scheiderer AN; Bahrami A; Master VA; Osunkoya AO
  • A randomized-controlled trial assessing the effect of intraoperative acupuncture on anesthesia-related parameters during gynecological oncology surgery.
    J Cancer Res Clin Oncol Volume: 149 Page(s): 8177 - 8189
    09/01/2023 Authors: Ben-Arye E; Hirsh I; Segev Y; Grach M; Master V; Eden A; Samuels N; Stein N; Gressel O; Ostrovsky L
  • Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR.
    Clin Genitourin Cancer Volume: 21 Page(s): e219 - e227
    08/01/2023 Authors: Yuan JH; Tanaka H; Patil D; Hakimi K; Soliman S; Meagher MF; Saidian A; Walia A; Dhanji S; Liu F
  • Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.
    Eur Urol Volume: 84 Page(s): e55 - e56
    08/01/2023 Authors: Shapiro DD; Karam JA; Master VA; Zemp LW; Sexton WJ; Matin SF; Spiess PE; Jason Abel E
  • Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Clin Genitourin Cancer Volume: 21 Page(s): 475 - 482.e4
    08/01/2023 Authors: Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J
  • Barriers and facilitators to physical activity prehabilitation in patients with kidney cancer.
    Eur J Oncol Nurs Volume: 65 Page(s): 102333
    08/01/2023 Authors: Paulo CM; Ali AA; Schmeusser BN; Midenberg E; Helman TA; Diller ML; Pisters MF; Ogan K; Master VA
  • 99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor.
    Clin Nucl Med Volume: 48 Page(s): e390 - e392
    08/01/2023 Authors: Ali AA; Sivathapandi T; Gupta R; Master VA; Marcus C
  • Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma.
    Curr Urol Rep Volume: 24 Page(s): 317 - 334
    07/01/2023 Authors: Schmeusser BN; Ali AA; Fintelmann FJ; Garcia JM; Williams GR; Master VA; Psutka SP
  • Prolonged Opioid Use Following Bladder Tumor Resection for Opioid-nave Patients.
    Urol Pract Volume: 10 Page(s): 345 - 351
    07/01/2023 Authors: Croll B; Patil D; Mason M; Narayan VM; Master V; Filson CP; Joshi SS
  • The 5-factor frailty index for radical nephrectomy: Simplifying personalized preoperative risk-stratification.
    Urol Oncol Volume: 41 Page(s): 329.e9 - 329.e10
    07/01/2023 Authors: Schmeusser BN; Master VA
  • Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
    Oncologist Volume: 28 Page(s): 494 - 500
    06/02/2023 Authors: Bergerot CD; Malhotra J; Bergerot P; Philip EJ; Castro DV; Hsu J; Mota ACDA; Cardoso de Azeredo A; Neto JNDM; Hutson T
  • Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey.
    Clin Genitourin Cancer Volume: 21 Page(s): 376 - 382
    06/01/2023 Authors: Prakash G; Arora A; Bandini M; Basile G; Pal M; Griffiths G; Cornes R; Zhu Y; Rodriguez A; Alberson M
  • Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
    J Nucl Med Volume: 64 Page(s): 586 - 591
    04/01/2023 Authors: Lawal IO; Jani AB; Adediran OA; Goyal S; Abiodun-Ojo OA; Dhere VR; Marcus CV; Joshi SS; Master VA; Patel PR
  • Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
    Clin Nucl Med Volume: 48 Page(s): e153 - e159
    04/01/2023 Authors: Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR
  • Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals.
    Eur Urol Open Sci Volume: 50 Page(s): 43 - 46
    04/01/2023 Authors: Shapiro DD; Karam JA; Zemp L; Master VA; Sexton WJ; Ghasemzadeh A; Schmeusser BN; Davaro F; Peak T; Patil D
  • IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA
    Volume: 209 Page(s): E133 - E134
    04/01/2023 Authors: Schmeusser BN; Palacios AR; Midenberg E; Nabavizadeh R; Ali A; Patil DH; Harvey RD; Bryksin J; Connor MJ; Ogan K
  • Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 28 Page(s): 239 - 245
    03/17/2023 Authors: Zhuang TZ; Ravindranathan D; Liu Y; Martini DJ; Brown JT; Nazha B; Russler G; Yantorni LB; Caulfield S; Carthon BC
  • Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment.
    Cancer Volume: 129 Page(s): 920 - 924
    03/15/2023 Authors: Schmeusser BN; Palacios AR; Midenberg ER; Nabavizadeh R; Patil DH; Harvey RD; Bryksin J; Connor MJ; Ogan K; Bilen MA
  • Proposal for reclassification of upstaged T1 and T2 and pathological T3 RCC based on improved alignment of survival analyses.
    Volume: 41
    02/20/2023 Authors: Meagher M; Cerrato C; Puri D; Liu F; Shah A; Ghassemzadeh S; Dhanji S; Wang L; Patil DH; Saito K
  • Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database.
    Volume: 41
    02/20/2023 Authors: Liu F; Wang L; Dhanji S; Meagher MF; Ghassemzadeh S; Shah A; Puri D; Nguyen M; Hakimi K; Cerrato C
  • Association of inflammation and depression in renal cell carcinoma.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Ali A; Patil DH; Midenberg E; Petrinec B; Bilen MA; Ogan K; Master VA
  • Validating the Palacios' future glomerular filtration rate equation with and without race.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Ali A; Patil DH; Palacios AR; Armas-Phan M; Ogan K; Master VA
  • Creatinine to cystatin C ratio and mortality in renal cell carcinoma.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Ali A; Patil DH; Midenberg E; Nabavizadeh R; Ogan K; Master VA
  • Effect of race-free estimated glomerular filtration rate equations (eGFR) on oncology clinical trial eligibility for Black patients.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Palacios AR; Midenberg E; Nabavizadeh R; Patil DH; Harvey RD; Bryksin J; Connor MJ; Ogan K; Bilen MA
  • Integrative Surgery: Embedding Complementary and Nonpharmacologic Therapies into Surgical Pain Management Strategies.
    Am Surg Volume: 89 Page(s): 192 - 196
    02/01/2023 Authors: Diller ML; Master V
  • Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-nave patients on survival in renal cell carcinoma.
    BJU Int Volume: 131 Page(s): 219 - 226
    02/01/2023 Authors: Nguyen MV; Walia A; Saidian A; Puri D; Meagher MF; Hakimi K; Tanaka H; Patil D; Yasuda Y; Saito K
  • Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus.
    J Immunother Precis Oncol Volume: 6 Page(s): 50 - 55
    02/01/2023 Authors: Master VA; Schmeusser BN; Osunkoya AO; Palacios AR; Midenberg E; Yantorni L; Ogan K; Bilen MA
  • CD8+ Tcell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
    Immunity Volume: 56 Page(s): 107 - 124.e5
    01/10/2023 Authors: Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R
  • Inguinal lymph node dissection in the era of minimally invasive surgical technology.
    Urol Oncol Volume: 41 Page(s): 1 - 14
    01/01/2023 Authors: Nabavizadeh R; Petrinec B; Nabavizadeh B; Singh A; Rawal S; Master V
  • Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.
    Urol Oncol Volume: 41 Page(s): 50.e19 - 50.e26
    01/01/2023 Authors: Midenberg E; Higgins MI; Schmeusser BN; Patil DH; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP
  • Mayo Adhesive Probability Score Does Not Have Prognostic Ability in Locally Advanced Renal Cell Carcinoma.
    J Kidney Cancer VHL Volume: 10 Page(s): 19 - 25
    01/01/2023 Authors: Schmeusser BN; Manalo TA; Liu Y; Shah YB; Ali A; Armas-Phan M; Patil DH; Nabavizadeh R; Ogan K; Master VA
  • Resection of retroperitoneal tumors with inferior vena cava involvement without caval reconstruction.
    J Surg Oncol Volume: 126 Page(s): 1306 - 1315
    12/01/2022 Authors: Palacios AR; Schmeusser BN; Midenberg E; Patil D; Xie L; Nabavizadeh R; Ogan K; Cardona K; Maithel SK; Master VA
  • Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline.
    J Clin Oncol Volume: 40 Page(s): 3998 - 4024
    12/01/2022 Authors: Mao JJ; Ismaila N; Bao T; Barton D; Ben-Arye E; Garland EL; Greenlee H; Leblanc T; Lee RT; Lopez AM
  • Response to a letter to the editor regarding inferior vena cava ligation.
    J Surg Oncol Volume: 126 Page(s): 1576 - 1577
    12/01/2022 Authors: Schmeusser BN; Palacios AR; Maithel S; Master VA
  • Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma.
    Data Brief Volume: 45 Page(s): 108724
    12/01/2022 Authors: Schmeusser BN; Patil DH; Midenberg E; Higgins MI; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP
  • Risk Stratification of Prostatic Adenocarcinoma Metastatic to the Lymph Nodes.
    Arch Pathol Lab Med Volume: 146 Page(s): 1345 - 1352
    11/01/2022 Authors: Bidot S; Monsrud A; Kline M; Speak A; Martini D; Bilen MA; Switchenko JM; Zhang Y; Gerges AG; Farhat GN
  • Evaluating the Safety and Efficacy of a Novel Polysaccharide Hemostatic System for Multidisciplinary Application: A Multicenter Prospective Randomized Controlled Trial
    Volume: 235 Page(s): S25 - S25
    11/01/2022 Authors: House MG; Kim RD; Tseng EE; Kaufman RP; Moon MR; Yopp AC; Master V
  • Association of grit and overall survival in patients undergoing nephrectomy for renal cell carcinoma.
    Transl Androl Urol Volume: 11 Page(s): 1503 - 1511
    11/01/2022 Authors: Midenberg ER; Schmeusser BN; Palacios A; Larsen K; Patil DH; Petrinec B; Croll B; Le T-L; Hong G; Lin FR
  • Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial.
    Lancet Volume: 400 Page(s): 1103 - 1116
    10/01/2022 Authors: Pal SK; Uzzo R; Karam JA; Master VA; Donskov F; Suarez C; Albiges L; Rini B; Tomita Y; Kann AG
  • Extramammary Paget's disease: Updates in the workup and management.
    Asian J Urol Volume: 9 Page(s): 451 - 459
    10/01/2022 Authors: Nabavizadeh R; Vashi KB; Nabavizadeh B; Narayan VM; Master VA
  • Utility of ultrasonography in preoperative assessment of tumor thrombi in kidney cancer.
    Can J Urol Volume: 29 Page(s): 11300 - 11306
    10/01/2022 Authors: Nabavizadeh R; Lee G; Bobrek K; Patil D; Alemozaffar M; Moreno C; Master VA
  • Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort.
    Clin Genitourin Cancer Volume: 20 Page(s): e276 - e282
    08/01/2022 Authors: Toide M; Saito K; Yasuda Y; Tanaka H; Fukuda S; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH
  • Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
    J Immunother Precis Oncol Volume: 5 Page(s): 52 - 57
    08/01/2022 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Hitron EE; Russler GA; Yantorni L; Caulfield S; Brown JT
  • Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.
    J Immunother Cancer Volume: 10
    07/01/2022 Authors: Carlisle JW; Jansen CS; Cardenas MA; Sobierajska E; Reyes AM; Greenwald R; Del Balzo L; Prokhnevska N; Kucuk O; Carthon BC
  • Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
    Oncologist Volume: 27 Page(s): 462 - 468
    06/08/2022 Authors: Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA
  • Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Cancer Volume: 128 Page(s): 2073 - 2084
    06/01/2022 Authors: Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS
  • How to Care and Minimize the Sequelae of Lower Extremity Lymphedema.
    Semin Oncol Nurs Volume: 38 Page(s): 151270
    06/01/2022 Authors: Bobrek K; Nabavizadeh R; Nabavizadeh B; Master V
  • Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations.
    Oncology (Williston Park) Volume: 36 Page(s): 276 - 287
    05/09/2022 Authors: Gentile D; Beeler D; Wang XS; Ben-Arye E; Zick SM; Bao T; Carlson LE; Ghelman R; Master V; Tripathy D
  • Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC).
    Urology Volume: 163 Page(s): 164 - 176
    05/01/2022 Authors: Meagher MF; Patil D; Saito K; Javier-Desloges JF; Bradshaw AW; Patel SH; Cotta BH; Yasuda Y; Eldefrawy A; Ghali F
  • Autologous Dendritic Vaccine Therapy in Metastatic Kidney Cancer: The ADAPT Trial and Beyond.
    Eur Urol Focus Volume: 8 Page(s): 651 - 653
    05/01/2022 Authors: Master VA; Uzzo RG; Bratlavsky G; Karam JA
  • RENAL FUNCTIONAL CHANGES AFTER CYSTECTOMY: WHO IMPROVES AND WHO DOES NOT?
    Volume: 207 Page(s): E971 - E971
    05/01/2022 Authors: Croll B; Patil D; Vashi K; Alemozaffar M; Master V; Filson C; Ogan K; Narayan V; Joshi S
  • A global approach to improving penile cancer care.
    Nat Rev Urol Volume: 19 Page(s): 231 - 239
    04/01/2022 Authors: Bandini M; Ahmed M; Basile G; Watkin N; Master V; Zhu Y; Prakash G; Rodriguez A; Ssebakumba MK; Leni R
  • Author Correction: A global approach to improving penile cancer care.
    Nat Rev Urol Volume: 19 Page(s): 253
    04/01/2022 Authors: Bandini M; Ahmed M; Basile G; Watkin N; Master V; Zhu Y; Prakash G; Rodriguez A; Ssebakumba MK; Leni R
  • Dissemination of validated health literacy videos: A tailored approach.
    Cancer Med Volume: 11 Page(s): 1678 - 1687
    04/01/2022 Authors: Blee SM; Facdol J; Dixon MD; Master V; Switchenko JM; Pentz RD
  • Extramammary Paget's Disease of genitourinary origin.
    Curr Opin Urol Volume: 32 Page(s): 211 - 215
    03/01/2022 Authors: Narayan VM; Master VA
  • Let's ask the patient: Self-reported quality-of-life measures help to predict kidney cancer mortality.
    Cancer Volume: 128 Page(s): 447 - 448
    02/01/2022 Authors: Nabavizadeh B; Master VA
  • Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
    Clin Genitourin Cancer Volume: 20 Page(s): 53 - 59
    02/01/2022 Authors: Martini DJ; Evans ST; Liu Y; Shabto JM; Uner OE; Olsen TA; Brown JT; Russler GA; Yantorni L; Caulfield S
  • Disparities in cancer-specific mortality between Asian and Caucasian patients with non-metastatic renal cell carcinoma: Analysis of the INMARC registry
    Volume: 81 Page(s): S207 - S208
    02/01/2022 Authors: Tanaka H; Fukuda S; Yasuda Y; Patil D; Saidian A; Walia A; Meagher M; Perry J; Nguyen M; Narasimhan R
  • Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS).
    Urol Oncol Volume: 40 Page(s): 12.e23 - 12.e30
    01/01/2022 Authors: Velaer K; Thomas I-C; Yang J; Kapphahn K; Metzner TJ; Golla A; Hoerner CR; Fan AC; Master V; Chertow GM
  • Low free testosterone is associated with increased mortality in frail surgical patients.
    Surg Open Sci Volume: 7 Page(s): 36 - 41
    01/01/2022 Authors: Lin F; Hong G; Kwon F; Pirani F; Makhani S; Henry M; Cooke I; Nabavizadeh R; Midenberg E; Mehta A
  • Examination of Provider and Patient Knowledge, Beliefs, and Preferences in Integrative Oncology at a National Cancer Institute-Designated Comprehensive Cancer Center.
    Integr Med Rep Volume: 1 Page(s): 66 - 75
    01/01/2022 Authors: Mascaro JS; Catic A; Srivastava M; Diller M; Rana S; Escoffery C; Master V
  • Case report: Important considerations for a renal mass on a solitary kidney in an adult with history of childhood wilms tumor.
    Front Oncol Volume: 12 Page(s): 971341
    01/01/2022 Authors: Schmeusser BN; Palacios AR; Midenberg E; Nabavizadeh R; Master VA; Joshi SS
  • Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital.
    J Health Care Poor Underserved Volume: 33 Page(s): 1569 - 1582
    01/01/2022 Authors: Dong A; Nabavizadeh R; Jiang JF; Washington SL; Master VA
  • Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma.
    Front Oncol Volume: 12 Page(s): 1068357
    01/01/2022 Authors: Schmeusser BN; Midenberg E; Palacios AR; Vettikattu N; Patil DH; Medline A; Higgins M; Armas-Phan M; Nabavizadeh R; Joshi SS
  • Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis.
    Front Oncol Volume: 12 Page(s): 995991
    01/01/2022 Authors: Keiner C; Meagher M; Patil D; Saito K; Walia A; Liu F; Dutt R; Miller N; Dhanji S; Saidian A
  • Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.
    Front Oncol Volume: 12 Page(s): 949400
    01/01/2022 Authors: Zhuang TZ; Harik L; Force S; Hadadi A; Bilen MA; Brown JT; Carthon BC; Goldman J; Kucuk O; Master VA
  • Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Stage.
    Cancers (Basel) Volume: 13
    12/13/2021 Authors: Bifarin OO; Gaul DA; Sah S; Arnold RS; Ogan K; Master VA; Roberts DL; Bergquist SH; Petros JA; Edison AS
  • Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer.
    Prostate Cancer Prostatic Dis Volume: 24 Page(s): 1093 - 1102
    12/01/2021 Authors: Asiri IM; Chen RC; Young HN; Codling J; Mandawat A; Beach SRH; Master V; Rajbhandari-Thapa J; Cobran EK
  • Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 1017 - 1025
    12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
  • Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders.
    Volume: 10 Page(s): 8412 - 8420
    12/01/2021 Authors: Cooke IJ; Patil D; Bobrek K; Narayan V; Master V; Rapaport M; Filson CP; Joshi SS
  • Palliative care use among bladder cancer patients treated with radical cystectomy.
    Urol Oncol Volume: 39 Page(s): 788.e1 - 788.e6
    11/01/2021 Authors: Ismaeel N; Patil D; Alemozaffar M; Filson CP; Master VA; Lay A
  • Integrative surgical oncology: A model of acute integrative oncology.
    Cancer Volume: 127 Page(s): 3929 - 3938
    11/01/2021 Authors: Diller ML; Master VA
  • Using Cystatin C and Serum Creatinine to Predict Renal Volume Post-nephrectomy
    Volume: 233 Page(s): E229 - E229
    11/01/2021 Authors: Petrinec B; Cooke I; Midenburg E; Ogan K; Master V
  • Sarcopenia and Modified Glasgow Prognostic Score Predict Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus
    Volume: 233 Page(s): E232 - E232
    11/01/2021 Authors: Higgins M; Manalo T; Patil DH; Nabavizadeh R; Martini D; Bilen MA; Master VA
  • DISSECTING INTRATUMORAL IMMUNE ORGANIZATION: DEFINING THE COMPARATIVE CELLULAR COMPOSITION OF TERTIARY LYMPHOID STRUCTURES T-CELL SUPPORTIVE ANTIGEN PRESENTING NICHES IN RENAL TUMORS
    Volume: 9 Page(s): A975 - A975
    11/01/2021 Authors: Jansen C; Sobierajska E; Greenwald R; Carlisle J; Mullane P; Prokhnevska N; Cardenas M; Bilen M; Osunkoya A; Master V
  • CD8 T CELL ACTIVATION IN CANCER IS COMPRISED OF TWO DISTINCT PHASES
    Volume: 9 Page(s): A686 - A686
    11/01/2021 Authors: Prokhnevska N; Cardenas M; Valanparambil R; Sobierajska E; Jansen C; Master V; Sanda M; Kissick H
  • STEM-LIKE CD4 T CELLS IN CANCER
    Volume: 9 Page(s): A669 - A669
    11/01/2021 Authors: Cardenas M; Prokhnevska N; Jansen C; Master V; Kissick H
  • Left renal vein nutcracker syndrome and concurrent IVC duplication: Surgical treatment.
    Urol Case Rep Volume: 39 Page(s): 101819
    11/01/2021 Authors: Midenberg E; Subu R; Sekhar A; Browne B; Duwayri Y; Master VA
  • Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): e1742 - e1750
    10/01/2021 Authors: Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA
  • Radiotherapy Does Not Increase the Frequency of Revision of Perineal Urethrostomy in Penile Cancer: A 20-year International Multicenter Experience
    Volume: 44 Page(s): S63 - S64
    10/01/2021 Authors: Johnstone P; de Vries H-M; Chipollini J; Boyd F; Korkes F; Albersen M; Roussel E; Jiang J; Master V; Brouwer O
  • Impact of radiation therapy on perineal urethrostomy for penile cancer.
    Clin Transl Radiat Oncol Volume: 30 Page(s): 84 - 87
    09/01/2021 Authors: A S Johnstone P; de Vries HM; Chipollini J; Daniel Grass G; Boyd F; Korkes F; Albersen M; Roussel E; Zhu Y; Ye D-W
  • NORMALIZATION OF PRE-OPERATIVE LABS AFTER CYTOREDUCTIVE NEPHRECTOMY IS ASSOCIATED WITH IMPROVED SURVIVAL
    Volume: 206 Page(s): E254 - E255
    09/01/2021 Authors: Esdaille A; Master V; Spiess P; Raman J; Watts A; Sexton W; Zemp L; Bilotta A; Patil D; Allen G
  • Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
    Urol Oncol Volume: 39 Page(s): 493.e9 - 493.e15
    08/01/2021 Authors: Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW
  • Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance.
    J Nucl Med Volume: 62 Page(s): 1089 - 1096
    08/01/2021 Authors: Abiodun-Ojo OA; Jani AB; Akintayo AA; Akin-Akintayo OO; Odewole OA; Tade FI; Joshi SS; Master VA; Fielder B; Halkar RK
  • Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC).
    Clin Genitourin Cancer Volume: 19 Page(s): e206 - e215
    08/01/2021 Authors: Patel SH; Derweesh IH; Saito K; Patil D; Meagher MF; Bindayi A; Eldefrawy A; Patel DN; Nasseri R; Yasuda Y
  • Outcomes of perineal urethrostomy for penile cancer: A 20-year international multicenter experience.
    Urol Oncol Volume: 39 Page(s): 500.e9 - 500.e13
    08/01/2021 Authors: de Vries HM; Chipollini J; Slongo J; Boyd F; Korkes F; Albersen M; Roussel E; Zhu Y; Ye D-W; Master V
  • Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics.
    J Proteome Res Volume: 20 Page(s): 3629 - 3641
    07/02/2021 Authors: Bifarin OO; Gaul DA; Sah S; Arnold RS; Ogan K; Master VA; Roberts DL; Bergquist SH; Petros JA; Fernndez FM
  • Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy.
    Eur Urol Focus Volume: 7 Page(s): 850 - 856
    07/01/2021 Authors: Pirani F; Makhani SS; Kim FY; Lay AH; Cimmino CB; Hartsell L; Spence A; Master VA; Ogan K
  • A Helpful Tool in the Renal Surgery Armamentarium: Dorsal Lumbotomy nephrectomy for Tumor in Patients with End-Stage Renal Disease.
    Urology Volume: 153 Page(s): 327 - 332
    07/01/2021 Authors: Cooke I; Sadruddin S; Patil D; Tripathi S; Nabavizadeh R; Joshi S; Narayan V; Ogan K; Master VA
  • Current practice patterns of society of urologic oncology members in performing inguinal lymph node staging/therapy for penile cancer: A survey study.
    Urol Oncol Volume: 39 Page(s): 439.e9 - 439.e15
    07/01/2021 Authors: Marilin N; Master VA; Pettaway CA; Spiess PE
  • Machine Learning in Body Composition Analysis.
    Eur Urol Focus Volume: 7 Page(s): 713 - 716
    07/01/2021 Authors: Higgins MI; Marquardt JP; Master VA; Fintelmann FJ; Psutka SP
  • Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    J Immunother Cancer Volume: 9
    07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
  • Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Cancer Volume: 127 Page(s): 1974 - 1983
    06/15/2021 Authors: Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP
  • Patient perspective on serving on the steering committee of the AURORAX-0087A trial for non-metastatic clear cell renal cell carcinoma
    Volume: 79 Page(s): S286 - S287
    06/01/2021 Authors: Giles R; Nair R; Azawi NH; Barber N; Bex A; Campi R; Capitanio U; Gatto F; Hakimi AA; Jarvinen P
  • Impact of post-operative proteinuria on development of CKD: Analysis of functional outcomes post nephrectomy
    Volume: 79 Page(s): S856 - S857
    06/01/2021 Authors: Meagher MF; Hakimi K; Soliman S; Yuan J; Patil D; Saito K; Javier-Desolges J; Yasuda Y; Wan F; Fujii Y
  • 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
    Lancet Volume: 397 Page(s): 1895 - 1904
    05/22/2021 Authors: Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
  • Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.02.009.
    Eur Urol Focus Volume: 7 Page(s): 666 - 667
    05/01/2021 Authors: Pirani F; Makhani S; Kim F; Lay A; Cimmino C; Hartsell L; Spence A; Master VA; Ogan K
  • What you need to know: updates in penile cancer staging.
    World J Urol Volume: 39 Page(s): 1413 - 1419
    05/01/2021 Authors: Khalil MI; Kamel MH; Dhillon J; Master V; Davis R; Hajiran AJ; Spiess PE
  • Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 397 - 405
    05/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS
  • CD8 T cell differentiation in cancer is comprised of two distinct phases
    Volume: 206
    05/01/2021 Authors: Prokhnevska N; Cardenas M; Valanparambil R; Jansen C; Master V; Sanda M; Kissick H
  • Inflammatory Markers in Cancer Immunotherapy.
    Biology (Basel) Volume: 10
    04/13/2021 Authors: Ravindranathan D; Master VA; Bilen MA
  • Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos.
    J Vis Exp
    03/21/2021 Authors: Steele S; Lin F; Le T-L; Medline A; Higgins M; Sandberg A; Evans S; Hong G; Williams MA; Bilen MA
  • Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
    BJU Int Volume: 127 Page(s): 311 - 317
    03/01/2021 Authors: Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW
  • Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case Controlled Study.
    J Urol Volume: 205 Page(s): 383 - 391
    02/01/2021 Authors: Xie L; Hong G; Nabavizadeh R; Patil D; Ethun CG; Ogan K; Maithel SK; Master VA
  • Who really knows the performance status: The physician or the patient?
    Cancer Volume: 127 Page(s): 339 - 341
    02/01/2021 Authors: Higgins MI; Master VA
  • Overlapping Urological Surgeries at a Tertiary Academic Center.
    Urology Volume: 148 Page(s): 118 - 125
    02/01/2021 Authors: Nabavizadeh R; Higgins MI; Patil D; Biebighauser Bens KC; Traor E; Master VA; Ogan K
  • EDITORIAL COMMENT.
    Urology Volume: 148 Page(s): 124 - 125
    02/01/2021 Authors: Nabavizadeh R; Higgins MI; Master VA; Ogan K
  • Health literacy and shared decision making in prostate cancer screening: Equality versus equity.
    Cancer Volume: 127 Page(s): 181 - 183
    01/15/2021 Authors: Washington SL; Master VA
  • Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations.
    Oncology (Williston Park) Volume: 35 Page(s): 35 - 41
    01/11/2021 Authors: Zhi WI; Gentile D; Diller M; Kinney A; Bao T; Master V; Wang XS
  • Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
    Volume: 28 Page(s): 100393
    01/01/2021 Authors: Martini DJ; Kline MR; Liu Y; Shabto JM; Carthon BC; Russler GA; Yantorni L; Hitron EE; Caulfield S; Goldman JM
  • Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
    Front Oncol Volume: 11 Page(s): 701345
    01/01/2021 Authors: Olsen TA; Martini DJ; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
  • Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Front Oncol Volume: 11 Page(s): 707050
    01/01/2021 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
  • Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma.
    Front Oncol Volume: 11 Page(s): 793808
    01/01/2021 Authors: Martini DJ; Jansen CS; Harik LR; Evans ST; Olsen TA; Master VA; Kissick HT; Bilen MA
  • Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma.
    Urology Volume: 146 Page(s): 152 - 157
    12/01/2020 Authors: Dreyfuss LD; Master VA; Raman JD; Spiess PE; Wells SA; Merrill SB; Peyton CC; Sankar D; Sohl B; Patil D
  • Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
    Volume: 108 Page(s): 1397
    12/01/2020 Authors: Jani A; Schreibmann E; Goyal S; Raghuveer H; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
  • Quantification of body composition in renal cell carcinoma patients: Comparing computed tomography and magnetic resonance imaging measurements.
    Eur J Radiol Volume: 132 Page(s): 109307
    11/01/2020 Authors: Higgins MI; Martini DJ; Patil DH; Steele S; Evans S; Petrinec BP; Psutka SP; Sekhar A; Bilen MA; Master VA
  • EFFICACY OF SEQUENTIAL IMMUNE CHECKPOINT INHIBITION (ICI) IN PATIENTS WITH GENITOURINARY MALIGNANCIES
    Volume: 8 Page(s): A154 - A155
    11/01/2020 Authors: Evans S; Martini D; Magod B; Olsen T; Brown J; Yantorni L; Ravindranathan D; Russler G; Caulfield S; Goldman J
  • BODY COMPOSITION MAY BE PROGNOSTIC AND PREDICTIVE OF CLINICAL OUTCOMES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
    Volume: 8 Page(s): A26 - A27
    11/01/2020 Authors: Martini D; Olsen TA; Goyal S; Liu Y; Evans S; Magod B; Brown J; Yantorni L; Russler G; Caulfield S
  • IMMUNE-RELATED ADVERSE EVENTS (IRAES) MAY INDICATE A FAVORABLE PROGNOSIS IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
    Volume: 8 Page(s): A380 - A381
    11/01/2020 Authors: Martini D; Evans S; Goyal S; Liu Y; Olsen TA; Magod B; Brown J; Yantorni L; Russler G; Caulfield S
  • Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.
    Ann Transplant Volume: 25 Page(s): e925865
    10/23/2020 Authors: Nabavizadeh R; Noorali AA; Makhani SS; Hong G; Holzman S; Patil DH; Kim FY; Tso PL; Turgeon NA; Ogan K
  • Sarcopenia and Neutrophil-Lymphocyte Ratio Are Associated with Overall Survival after Surgery for Localized Renal Cell Carcinoma
    Volume: 231 Page(s): S339 - S339
    10/01/2020 Authors: Higgins M; Nabavizadeh R; Patil DH; Ogan K; Kissick H; Bilen MA; Master V
  • International, Multi-Institutional Study of 1330 Patients Evaluating the Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Renal Cell Carcinoma
    Volume: 231 Page(s): S338 - S339
    10/01/2020 Authors: Nabavizadeh R; Patil DH; Medline A; Fukuda S; Yasuda Y; Ogan K; Master V
  • Concordance of Using MRI vs CT Images for Linear Measurement Analysis in the Quantitation of Abdominal Skeletal Muscle: Implications for Sarcopenia Measurement
    Volume: 231 Page(s): S335 - S336
    10/01/2020 Authors: Medline A; Nabavizadeh R; Evans S; Sandberg A; Le T-L; Patil DH; Master V
  • Re: Prospective Randomized Trial Comparing the Safety and Clarity of Water versus Saline Irrigant in Ureteroscopy.
    J Urol Volume: 204 Page(s): 874
    10/01/2020 Authors: Assimos DG
  • Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation.
    Urol Oncol Volume: 38 Page(s): 706 - 712
    09/01/2020 Authors: Nabavizadeh R; Bobrek K; Master VA
  • Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
    Int J Urol Volume: 27 Page(s): 790 - 797
    09/01/2020 Authors: Obeng RC; Arnold RS; Ogan K; Master VA; Pattaras JG; Petros JA; Osunkoya AO
  • Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer.
    J Clin Med Volume: 9
    08/03/2020 Authors: Nabavizadeh R; Petrinec B; Necchi A; Tsaur I; Albersen M; Master V
  • A Rare Case of Vena Cava Tumor Thrombus Associated With Epithelioid Angiomyolipoma.
    Urology Volume: 142 Page(s): e4 - e7
    08/01/2020 Authors: Lee G; Nabavizadeh R; Osunkoya AO; Master VA
  • Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma.
    Volume: 141 Page(s): 101 - 107
    07/01/2020 Authors: Patil D; Le T-L; Bens KB; Alemozaffar M; Lay A; Pattaras J; Filson CP; Ogan K; Bilen MA; Master VA
  • Reply to Body fat indices and survival in immunotherapy-treated patients with cancer.
    Cancer Volume: 126 Page(s): 3157 - 3159
    07/01/2020 Authors: Martini DJ; Liu Y; Master VA; Harvey RD; Bilen MA
  • Tumor-targeted oncolytic adenovirus demonstrates high cytotoxicity for human lung and renal cell carcinomas independently of the level of tumor PD-L1 expression.
    Volume: 38
    05/20/2020 Authors: Yao J; Atasheva S; Young C; Master VA; Shayakhmetov D
  • Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma.
    Clin Cancer Res Volume: 26 Page(s): 2327 - 2336
    05/15/2020 Authors: Figlin RA; Tannir NM; Uzzo RG; Tykodi SS; Chen DYT; Master V; Kapoor A; Vaena D; Lowrance W; Bratslavsky G
  • In Reply.
    Oncologist Volume: 25 Page(s): e876
    05/01/2020 Authors: Bilen MA; Master VA; Harvey RD
  • 18F-fluciclovine PET/CT findings are predictive of failure-free survival following salvage radiotherapy in post-prostatectomy patients with biochemical recurrence.
    Volume: 61
    05/01/2020 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Tade F; Master V; Patel P; Shelton J; Kucuk O
  • CD4 T cell phenotypes differentially modulate the CD8 T cell response in kidney cancer
    Volume: 204
    05/01/2020 Authors: Cardenas MA; Prokhnevska N; Jansen CS; Master VA; Kissick H
  • Tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response
    Volume: 204
    05/01/2020 Authors: Prokhnevska N; Cardenas M; Jansen C; Valanparambil R; Master V; Sanda M; Kissick H
  • Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
    Clin Genitourin Cancer Volume: 18 Page(s): 111 - 116.e1
    04/01/2020 Authors: Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
  • Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
    Cancer Med Volume: 9 Page(s): 2752 - 2760
    04/01/2020 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Brown J; Hitron EE; Russler GA; Caulfield S; Kissick H; Alemozaffar M
  • ADDRESSING HEALTH LITERACY IMPROVES SHARED DECISION MAKING IN UNDERSERVED AFRICAN AMERICAN PROSTATE CANCER PATIENTS
    Volume: 203 Page(s): E817 - E818
    04/01/2020 Authors: Kilbridge K; Martin-Doyle W; Filson C; Quoc-Dien T; Williams S; Master V
  • LONG-TERM FUNCTIONAL OUTCOMES OF INFERIOR VENA CAVA RESECTION COMPARED TO THROMBECTOMY IN RENAL CELL CARCINOMA PATIENTS: A RETROSPECTIVE, CASE-CONTROLLED STUDY
    Volume: 203 Page(s): E1004 - E1004
    04/01/2020 Authors: Xie L; Hong G; Patil D; Nabavizadeh R; Lin F; Ethun CG; Maithel SK; Cardona K; Ogan K; Master VA
  • LOW FREE TESTOSTERONE AND FRAILTY PREDICT OVERALL SURVIVAL IN SURGICAL PATIENTS
    Volume: 203 Page(s): E859 - E859
    04/01/2020 Authors: Lin F; Hong G; Kim F; Pirani F; Makhani S; Henry M; Cooke I; Nabavizadeh R; Ritenour CWM; Alemozaffar M
  • Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
    Oncologist Volume: 25 Page(s): e528 - e535
    03/01/2020 Authors: Bilen MA; Martini DJ; Liu Y; Shabto JM; Brown JT; Williams M; Khan AI; Speak A; Lewis C; Collins H
  • Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 25 Page(s): e484 - e491
    03/01/2020 Authors: Martini DJ; Liu Y; Shabto JM; Carthon BC; Hitron EE; Russler GA; Caulfield S; Kissick HT; Harris WB; Kucuk O
  • Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study
    Volume: 38
    02/20/2020 Authors: Dutt R; Meagher MF; Patil D; Saito K; Patel D; Ghali F; Keiner C; Miller N; Bradshaw A; Wan F
  • Association of De Ritis Ratio and Neutrophil Lymphocyte Ratio with renal functional decline and all-cause mortality in renal cell carcinoma
    Volume: 38
    02/20/2020 Authors: Keiner C; Meagher M; Patil D; Saito K; Patel D; Ghali F; Dutt R; Miller N; Bradshaw A; Wan F
  • Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI)
    Volume: 38
    02/20/2020 Authors: Brown JT; Liu Y; Martini DJ; Shabto JM; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS; Kissick H
  • Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI)
    Volume: 38
    02/20/2020 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS
  • Impact of oncological versus nononcological on survival outcomes in African Americans with renal cell carcinoma
    Volume: 38
    02/20/2020 Authors: Meagher MF; Bradshaw A; Patil DH; Saito K; Cotta B; Yasuda Y; Eldefrawy A; Fujii Y; Master VA; Derweesh I
  • Efficacy of Percutaneous Tibial Nerve Stimulation for Overactive Bladder in Women and Men at a Safety Net Hospital.
    J Urol Volume: 203 Page(s): 385 - 391
    02/01/2020 Authors: Jiang JF; Leung AK; Pettitt-Schieber B; Nabavizadeh R; Thomas RL; Brown M; Hafford D; Lay AH; Hammett J; Carney KJ
  • Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
    Cancer Volume: 126 Page(s): 575 - 582
    02/01/2020 Authors: Martini DJ; Kline MR; Liu Y; Shabto JM; Williams MA; Khan AI; Lewis C; Collins H; Akce M; Kissick HT
  • Reply by Authors.
    J Urol Volume: 203 Page(s): 391
    02/01/2020 Authors: Jiang JF; Leung AK; Pettitt-Schieber B; Nabavizadeh R; Thomas RL; Brown M; Hafford D; Lay AH; Hammett J; Carney KJ
  • Multidisciplinary Care of Adult Wilms' Tumor During Pregnancy: A Case Report and Review of the Literature.
    Clin Genitourin Cancer Volume: 18 Page(s): e1 - e4
    02/01/2020 Authors: Brown JT; Harik LR; Barbee MS; Esiashvili N; Badell ML; Goldsmith KC; Master VA; Bilen MA
  • The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.
    Eur Urol Focus Volume: 6 Page(s): 104 - 111
    01/15/2020 Authors: Peyton CC; Abel EJ; Chipollini J; Boulware DC; Azizi M; Karam JA; Margulis V; Master VA; Matin SF; Raman JD
  • Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis.
    Asian J Urol Volume: 7 Page(s): 29 - 36
    01/01/2020 Authors: Laganosky D; Filson CP; Patil D; Master VA
  • The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients.
    Oncoimmunology Volume: 9 Page(s): 1747731
    01/01/2020 Authors: Margaroli C; Cardenas MA; Jansen CS; Moon Reyes A; Hosseinzadeh F; Hong G; Zhang Y; Kissick H; Tirouvanziam R; Master VA
  • Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report.
    Front Oncol Volume: 10 Page(s): 622134
    01/01/2020 Authors: Bilen MA; Jiang JF; Jansen CS; Brown JT; Harik LR; Sekhar A; Kissick H; Maithel SK; Kucuk O; Carthon B
  • Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
    Oncologist
    12/05/2019 Authors: Bilen MA; Martini DJ; Liu Y; Shabto JM; Brown JT; Williams M; Khan AI; Speak A; Lewis C; Collins H
  • Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist
    12/05/2019 Authors: Martini DJ; Liu Y; Shabto JM; Carthon BC; Hitron EE; Russler GA; Caulfield S; Kissick HT; Harris WB; Kucuk O
  • Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
    Invest New Drugs Volume: 37 Page(s): 1198 - 1206
    12/01/2019 Authors: Martini DJ; Liu Y; Shabto JM; Lewis C; Kline MR; Collins H; Akce M; Kissick HT; Carthon BC; Shaib WL
  • An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
    Nature Volume: 576 Page(s): 465 - 470
    12/01/2019 Authors: Jansen CS; Prokhnevska N; Master VA; Sanda MG; Carlisle JW; Bilen MA; Cardenas M; Wilkinson S; Lake R; Sowalsky AG
  • Videos improve patient understanding of misunderstood chemotherapy terminology.
    Cancer Volume: 125 Page(s): 4011 - 4018
    11/15/2019 Authors: Pentz RD; Lohani M; Hayban M; Switchenko JM; Dixon MD; DeFeo RJ; Orloff GM; Jani AB; Master VA
  • How tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response
    Volume: 7
    11/06/2019 Authors: Prokhnevska N; Valanparambil R; Jansen C; Master V; Sanda M; Kissick H
  • A Preoperative Cognitive Screening Test Predicts Increased Length of Stay in a Frail Population: A Retrospective Case-Control Study.
    Anesth Analg Volume: 129 Page(s): 1283 - 1290
    11/01/2019 Authors: O'Reilly-Shah VN; Hemani S; Davari P; Glowka L; Gebhardt E; Hill L; Lee S; Master VA; Rodriguez AD; Garca PS
  • 18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.
    J Nucl Med Volume: 60 Page(s): 1531 - 1536
    11/01/2019 Authors: Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo OO; Tade FI; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Fei B
  • Optimizing cystectomy outcomes.
    Cancer Volume: 125 Page(s): 3502 - 3503
    10/15/2019 Authors: Porten SP; Master VA
  • Optimizing cystectomy outcomes
    CANCER Volume: 125 Page(s): 3502 - 3503
    10/15/2019 Authors: Porten SP; Master VA
  • Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.
    Eur J Surg Oncol Volume: 45 Page(s): 1983 - 1992
    10/01/2019 Authors: Gonzlez J; Gaynor JJ; Martnez-Salamanca JI; Capitanio U; Tilki D; Carballido JA; Chantada V; Daneshmand S; Evans CP; Gasch C
  • A randomized, controlled trial for transurethral treatment of bladder tumors using PlasmaButton vaporization electrode or monopolar loop electrocautery.
    Can J Urol Volume: 26 Page(s): 9908 - 9915
    10/01/2019 Authors: Alemozaffar M; Ogan K; Filson CP; Patil D; Lee G; Canter DJ; Hong G; Master VA
  • Outcomes in Renal Cell Carcinoma Patients Undergoing IVC Ligation vs Thrombectomy: A Retrospective, Case-Controlled Study
    Volume: 229 Page(s): S318 - S319
    10/01/2019 Authors: Xie L; Hong G; Patil D; Nabavizadeh R; Ethun CG; Maithel SK; Cardona K; Ogan K; Master VA
  • Variation in Estimated Glomerular Filtration Rate Values Before Nephrectomy Based on Cystatin C, Chronic Kidney Disease Epidemiology Collaboration, Cockcroft-Gault, and Modification of Diet in Renal Disease Formulas
    Volume: 229 Page(s): S323 - S323
    10/01/2019 Authors: Hong G; Henry M; Pirani F; Patil D; Ogan K; Connor M; Bilen MA; Harvey RD; Bryksin J; Master V
  • Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
    BMC Cancer Volume: 19 Page(s): 857
    08/29/2019 Authors: Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL
  • MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement.
    Appl Physiol Nutr Metab Volume: 44 Page(s): 814 - 819
    08/01/2019 Authors: Khan AI; Reiter DA; Sekhar A; Sharma P; Safdar NM; Patil DH; Psutka SP; Small WC; Bilen MA; Ogan K
  • Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
    J Urol Volume: 202 Page(s): 413 - 421
    08/01/2019 Authors: Fei B; Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo O; Tade F; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM
  • Avoiding the Need for Bowel Anastomosis during Pelvic Exenteration-Urinary Sigmoid or Descending Colon Conduit-Short and Long Term Complications.
    Volume: 129 Page(s): 228 - 233
    07/01/2019 Authors: Alemozaffar M; Nam CS; Said MA; Patil D; Carney KJ; David S; Master VA
  • CD8 T-cell infiltration into renal tumors requires a supportive antigen-presenting niche
    Volume: 79
    07/01/2019 Authors: Jansen CS; Prokhnevska N; Master VA; Carlisle JW; Bilen MA; Reyes AM; Kissick HT
  • Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy.
    Clin Genitourin Cancer Volume: 17 Page(s): e494 - e504
    06/01/2019 Authors: Taylor MA; Alemozaffar M; Master VA; Sanda MG; Filson CP
  • Novel risk stratification criteria of metastatic renal cell carcinoma (mRCC) patients (pts) treated with immune checkpoint inhibitors (ICI).
    Volume: 37
    05/20/2019 Authors: Martini DJ; Liu Y; Shabto JM; Carthon BC; Russler G; Hitron E; Caulfield S; Kissick H; Harris W; Kucuk O
  • The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
    Future Oncol Volume: 15 Page(s): 1683 - 1695
    05/01/2019 Authors: Patel HD; Puligandla M; Shuch BM; Leibovich BC; Kapoor A; Master VA; Drake CG; Heng DY; Lara PN; Choueiri TK
  • Local Control Is Not the Only Outcome of Interest in RCC
    ONCOLOGY-NEW YORK Volume: 33 Page(s): 172 - 172
    05/01/2019 Authors: Master V
  • [F-18]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
    Volume: 60
    05/01/2019 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Odewole O; Tade F; Nieh P; Master V; Patel P
  • Minimally invasive approaches to the inguinal nodes in cN0 patients.
    Curr Opin Urol Volume: 29 Page(s): 165 - 172
    03/01/2019 Authors: Nabavizadeh R; Master V
  • Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support.
    Urol Pract Volume: 6 Page(s): 93 - 99
    03/01/2019 Authors: Berry DL; Hong F; Halpenny B; Sanda MG; Master VA; Filson CP; Chang P; Chien GW; Underhill M; Fox E
  • Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Volume: 32
    03/01/2019 Authors: Xiong M-J; Kissick H; Master V; Osunkoya AO
  • High Risk Clinical Features Correspond to a Definitive Pathologic Diagnosis and Poor Overall Outcome in Penile Calcific Uremic Arteriolopathy (CUA)
    Volume: 99
    03/01/2019 Authors: Singh J; Master V; Ellis C
  • High Risk Clinical Features Correspond to a Definitive Pathologic Diagnosis and Poor Overall Outcome in Penile Calcific Uremic Arteriolopathy (CUA)
    Volume: 32
    03/01/2019 Authors: Singh J; Master V; Ellis C
  • Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Volume: 99
    03/01/2019 Authors: Xiong M-J; Kissick H; Master V; Osunkoya AO
  • Analysis of toxicity and clinical outcomes (CO) in full versus reduced dose cabozantinib (cabo) in metastatic renal cell carcinoma (mRCC) patients (pts).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Association of inflammation and clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Sites of metastases (mets) and their association with clinical outcomes (CO) in urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Inflammatory markers at baseline (C1) and cycle 3 (C3) and their association with clinical outcomes in urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Body mass index (BMI) and toxicities and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Sarcopenia is independently associated with decreased overall survival after surgery for inferior vena cava tumor thrombus patients.
    Volume: 37
    03/01/2019 Authors: Williams M; Nabavizadeh R; Khan AI; Patil DH; Psutka SP; Sekhar A; Ogan K; Bilen MA; Master VA
  • Providers' inability to estimate health literacy among African American (AA) patients (pts) with early prostate cancer (PCa).
    Volume: 37
    03/01/2019 Authors: Martin-Doyle W; Kilbridge KL; Regan S; Filson CP; Quoc-Dien T; Williams S; Master VA
  • Health literacy is a barrier to shared decision making in early prostate cancer (PCA) among African American (AA) men.
    Volume: 37
    03/01/2019 Authors: Martin-Doyle W; Filson CP; Regan S; Quoc-Dien T; Williams S; Master VA; Kilbridge KL
  • Disparities in survival outcomes in African Americans in renal cell carcinoma: Impact of oncological versus nononcological factors.
    Volume: 37
    03/01/2019 Authors: Meagher MF; Bradshaw A; Anyakora D; Patil DH; Saito K; Cotta B; Yasuda Y; Eldefrawy A; Ryan S; Nasseri R
  • Development and validation of a novel scoring index (C-reactive protein, age, race, and tumor size) to predict renal functional decline post partial nephrectomy.
    Volume: 37
    03/01/2019 Authors: Meagher MF; Patil DH; Saito K; Cotta B; Yasuda Y; Bradshaw A; Eldefrawy A; Ryan S; Nasseri R; Anyakora D
  • Association of elevated C-reactive protein with oncologic outcomes in renal CELL carcinoma: A multicenter analysis.
    Volume: 37
    03/01/2019 Authors: Patel SH; Meagher MF; Saito K; Patil D; Bindayi A; Eldefrawy A; Ryan S; Cotta B; Yim K; Nasseri R
  • Sequential immunotherapy and association with clinical outcomes in advanced-stage cancer patients
    Volume: 7
    02/01/2019 Authors: Bilen M; Martini D; Liu Y; Lewis C; Collins H; Shabto J; Akce M; Kissick H; Carthon B; Shaib W
  • Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
    BMC Med Inform Decis Mak Volume: 19 Page(s): 6
    01/09/2019 Authors: Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW
  • Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Volume: 42 Page(s): 36 - 41
    01/01/2019 Authors: Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B
  • The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
    Cancer Volume: 125 Page(s): 127 - 134
    01/01/2019 Authors: Bilen MA; Martini DJ; Liu Y; Lewis C; Collins HH; Shabto JM; Akce M; Kissick HT; Carthon BC; Shaib WL
  • Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
    Ann Oncol Volume: 29 Page(s): 2371 - 2378
    12/01/2018 Authors: Gross-Goupil M; Kwon TG; Eto M; Ye D; Miyake H; Seo SI; Byun S-S; Lee JL; Master V; Jin J
  • The value of a cross-discipline team-based approach for resection of renal cell carcinoma with IVC tumor thrombus: A report of a large, contemporary, single-institution experience.
    J Surg Oncol Volume: 118 Page(s): 1219 - 1226
    12/01/2018 Authors: Master VA; Ethun CG; Kooby DA; Staley CA; Maithel SK
  • Lymphadenectomy for High-Risk Prostate Cancer Patients: What Is Going on in Georgia?
    Volume: 227 Page(s): S281 - S282
    10/01/2018 Authors: Henry M; Taylor M; Kim F; Pattaras JG; Alemozaffar M; Master V; Filson CP
  • New Preoperative Inflammatory Score Is an Independent and Significant Predictor of Overall Survival in Localized Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E244 - E244
    10/01/2018 Authors: Melnick KR; Khan AI; Patil D; Kim F; Patel AP; Bilen MA; Kucuk O; Filson CP; Ogan K; Master V
  • High Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in Localized and Metastatic Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E243 - E243
    10/01/2018 Authors: Khan AI; Melnick KR; Patil D; Kim F; Laganosky DD; Bilen MA; Kucuk O; Filson CP; Ogan K; Master V
  • Serial Measurements of C-Reactive Protein: Albumin Ratio Can Stratify Risk and Survival in Patients with Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E245 - E245
    10/01/2018 Authors: Laganosky DD; Khan AI; Patil D; Lay AH; Pattaras JG; Bilen MA; Kucuk O; Ogan K; Master V
  • Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results.
    Volume: 29 Suppl 8 Page(s): viii303
    10/01/2018 Authors: Gross-Goupil M; Kwon TG; Eto M; Ye D; Miyake H; Seo SI; Byun SS; Lee JL; Master V; Jin J
  • Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO).
    Volume: 29 Suppl 8 Page(s): viii42
    10/01/2018 Authors: Bilen MA; Martini DJ; Shabto JM; Liu Y; Khan AI; Williams MA; Lewis C; Collins HH; Kissick H; Carthon BC
  • Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO).
    Ann Oncol Volume: 29 Suppl 8 Page(s): viii433
    10/01/2018 Authors: Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins HH; Akce M; Kissick H; Carthon BC; Shaib WL
  • Interobserver Variability in Squamous Cell Carcinoma of the Penis: Analyzing the Degree of Differentiation by Pathologic Subspecialty With Correlation to Pathologic Stage
    Volume: 150 Page(s): S30 - S31
    10/01/2018 Authors: Mullane P; Willis B; Dimarco M; Plantinga L; Stoff B; Master V; Osunkoya A; Ellis C
  • Role of metastasis-directed treatment in kidney cancer.
    Cancer Volume: 124 Page(s): 3641 - 3655
    09/15/2018 Authors: Psutka SP; Master VA
  • Editorial Comment.
    J Urol Volume: 200 Page(s): 527
    09/01/2018 Authors: Master V
  • Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.
    Eur Urol Oncol Volume: 1 Page(s): 292 - 304
    09/01/2018 Authors: Psutka SP; Barocas DA; Catto JWF; Gore JL; Lee CT; Morgan TM; Master VA; Necchi A; Rouprt M; Boorjian SA
  • Author Reply.
    Urology Volume: 117 Page(s): 106 - 107
    07/01/2018 Authors: Leung AK; Moses KA; Master VA
  • The Clinical Course of Patients With Prostate-Specific Antigen 100ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening.
    Urology Volume: 117 Page(s): 101 - 107
    07/01/2018 Authors: Leung AK; Hugar L; Patil D; Wong L; Carthon B; Carney KJ; Birdsong G; Moses KA; Master VA
  • Blood based biomarkers and association with clinical outcome (CO) in advanced stage patients (pts) treated with immunotherapy (IO)
    Volume: 78
    07/01/2018 Authors: Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Pillai R
  • Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab.
    Clin Genitourin Cancer Volume: 16 Page(s): e563 - e575
    06/01/2018 Authors: Bilen MA; Dutcher GMA; Liu Y; Ravindranathan D; Kissick HT; Carthon BC; Kucuk O; Harris WB; Master VA
  • Editorial Comment.
    J Urol Volume: 199 Page(s): 1524
    06/01/2018 Authors: Master V
  • Comparing Outcomes of Robotic and Open Inguinal Lymph Node Dissection in Patients with Carcinoma of the Penis EDITORIAL COMMENT
    JOURNAL OF UROLOGY Volume: 199 Page(s): 1525 - 1525
    06/01/2018 Authors: Master V
  • Early change in blood-based biomarkers and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)
    Volume: 36
    05/20/2018 Authors: Martini DJ; Liu Y; Lewis CM; Shabto JM; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Pillai RN
  • Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.
    Eur J Radiol Volume: 102 Page(s): 1 - 8
    05/01/2018 Authors: Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V
  • The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus.
    Urology Volume: 115 Page(s): 119 - 124
    05/01/2018 Authors: Hutchinson R; Rew C; Chen G; Woldu S; Krabbe L-M; Meissner M; Sheth K; Singla N; Shakir N; Master VA
  • The role of fluciclovine (F-18) PET/CT directed, 3D ultrasound-guided fusion targeted biopsy in the detection of biochemically recurrent prostate cancer
    Volume: 59
    05/01/2018 Authors: Abiodun-Ojo O; Fei B; Nieh P; Master V; Akintayo A; Tade F; Akin-Akintayo O; Alemozaffar M; Osunkoya A; Goodman M
  • Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
    Clin Genitourin Cancer Volume: 16 Page(s): e443 - e450
    04/01/2018 Authors: Chipollini J; Abel EJ; Peyton CC; Boulware DC; Karam JA; Margulis V; Master VA; Zargar-Shoshtari K; Matin SF; Sexton WJ
  • RISING PREVALENCE OF NODE-POSTIVE PROSTATE CANCER AMONG MEN TREATED WITH RADICAL PROSTATECTOMY
    Volume: 199 Page(s): E984 - E984
    04/01/2018 Authors: Taylor M; Henry M; Kim F; Master V; Alemozaffar M; Pattaras J; Filson C
  • RANDOMIZED TRIAL COMPARING THE SAFETY AND CLARITY OF WATER VERSUS SALINE IRRIGANT IN URETEROSCOPY
    Volume: 199 Page(s): E747 - E747
    04/01/2018 Authors: Pirani F; Makhani S; Kim F; Lay A; Cimmino C; Hartsell L; Spence A; Master V; Ogan K
  • Validation of a novel preoperative inflammatory score in localized, clear cell RCC.
    Volume: 36
    02/20/2018 Authors: Melnick KR; Patil DH; Khan AI; Kim FY; Bilen MA; Carthon BC; Kucuk O; Filson CP; Ogan K; Kissick HT
  • Evaluation of preoperative C-reactive protein: Albumin ratio in patients with clear cell renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Patil DH; Williams S; Torlak M; Alemozaffar M; Lay A; Pattaras J; Kucuk O; Carthon BC; Bilen MA; Ogan K
  • Single center validation of neutrophil-to-lymphocyte ratio in localized and metastatic clear cell renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Melnick KR; Patil DH; Khan AI; Kim FY; Torlak M; Bilen MA; Kucuk O; Carthon BC; Filson CP; Ogan K
  • Defining individual recurrence risk following surgery for high risk non-metastatic renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Abel EJ; Raman JD; Shapiro DD; Chan W; Allen GO; Patil D; Master VA
  • Level of preoperative CRP as an independent predictor of survival in patients after nephrectomy for renal cell carcinoma: Long-term outcomes.
    Volume: 36
    02/20/2018 Authors: Saon M; Patil DH; Ding T; Kim FY; Torlak M; Ogan K; Master VA
  • Immunologic profile and prognostic significance of tumor-infiltrating lymphocytes in renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Khan AI; Jansen CS; Carlisle JW; Melnick KR; Kim KS; Hosseinzadeh F; Prokhnevska N; Bilen MA; Master VA; Kissick HT
  • Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
    Urol Oncol Volume: 36 Page(s): 79.e11 - 79.e17
    02/01/2018 Authors: Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC
  • A semiautomatic algorithm for three-dimensional segmentation of the prostate on CT images using shape and local texture characteristics.
    Proc SPIE Int Soc Opt Eng Volume: 10576
    02/01/2018 Authors: Shahedi M; Ma L; Halicek M; Guo R; Zhang G; Schuster DM; Nieh P; Master V; Fei B
  • Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
    J Urol Volume: 199 Page(s): 89 - 97
    01/01/2018 Authors: Berry DL; Hong F; Blonquist TM; Halpenny B; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA
  • Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma.
    Oncoimmunology Volume: 7 Page(s): e1413519
    01/01/2018 Authors: Kim KS; Sekar RR; Patil D; Dimarco MA; Kissick HT; Bilen MA; Osunkoya AO; Master VA
  • Paraneoplastic Thrombocytopenia Cured With Nephrectomy and Vena Cava Thrombectomy: Concurrent Hematology and Oncology Management Conundrums.
    J Oncol Pract Volume: 13 Page(s): 767 - 768
    11/01/2017 Authors: Melnick KR; Chang C; Antun A; Maithel SK; Master VA
  • Cognitive Impairment and Overall Survival in Frail Surgical Patients.
    J Am Coll Surg Volume: 225 Page(s): 590 - 600.e1
    11/01/2017 Authors: Makhani SS; Kim FY; Liu Y; Ye Z; Li JL; Revenig LM; Vaughan CP; Johnson TM; Garca PS; Ogan K
  • A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma.
    Asian J Urol Volume: 4 Page(s): 230 - 238
    10/01/2017 Authors: Sekar RR; Patil D; Baum Y; Pearl J; Bausum A; Bilen MA; Kucuk O; Harris WB; Carthon BC; Alemozaffar M
  • Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.
    J Urol Volume: 198 Page(s): 810 - 816
    10/01/2017 Authors: Abel EJ; Masterson TA; Karam JA; Master VA; Margulis V; Hutchinson R; Lorentz CA; Bloom E; Bauman TM; Wood CG
  • A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial.
    Ann Surg Oncol Volume: 24 Page(s): 3237 - 3244
    10/01/2017 Authors: Postlewait LM; Farley CR; Diller ML; Martin B; Hart Squires M; Russell MC; Rizzo M; Ogan K; Master V; Delman K
  • Technical considerations to minimize complications of inguinal lymph node dissection.
    Transl Androl Urol Volume: 6 Page(s): 820 - 825
    10/01/2017 Authors: Gupta MK; Patel AP; Master VA
  • Long-Term Experience with Laparoscopic Renal Cryoablation Using Real-Time Intraoperative Thermal Monitoring
    Volume: 225 Page(s): S207 - S208
    10/01/2017 Authors: Laganosky D; Henry M; Kim F; Nieh PT; Master VA; Pattaras JG
  • Value of a Cross-Discipline Team-Based Approach of Surgical and Urologic Oncologists for Resection of Renal Cell Carcinoma with IVC Tumor Thrombus: A Report of the Largest Contemporary Single-Institution Experience
    Volume: 225 Page(s): S210 - S210
    10/01/2017 Authors: Ethun CG; Maithel SK; Kooby DA; Staley CA; Master VA
  • Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.
    CA Cancer J Clin Volume: 67 Page(s): 362 - 377
    09/01/2017 Authors: Ethun CG; Bilen MA; Jani AB; Maithel SK; Ogan K; Master VA
  • Patient Frailty and Discharge Disposition Following Radical Cystectomy.
    Clin Genitourin Cancer Volume: 15 Page(s): e615 - e621
    08/01/2017 Authors: Pearl JA; Patil D; Filson CP; Arya S; Alemozaffar M; Master VA; Ogan K
  • Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
    J Urol Volume: 198 Page(s): 281 - 288
    08/01/2017 Authors: Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF
  • Contemporary management of patients with penile cancer and lymph node metastasis.
    Nat Rev Urol Volume: 14 Page(s): 335 - 347
    06/01/2017 Authors: Leone A; Diorio GJ; Pettaway C; Master V; Spiess PE
  • Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.
    Tumour Biol Volume: 39 Page(s): 1010428317705514
    06/01/2017 Authors: Harris WB; Zhang C; Liu Y; Robertson DK; Akbashev MY; Lingerfelt BM; Kucuk O; Carthon BC; Gillespie TW; Osunkoya AO
  • Single institution experience on papillary renal cell carcinoma PD-1/13D-L1 expression, pathological analysis, and outcomes after nephrectomy.
    Volume: 35
    05/20/2017 Authors: Carthon BC; Tabba M; Harris W; Kucuk O; Master VA; Ogan K; Osunkoya A; Ellis C
  • Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
    Urol Oncol Volume: 35 Page(s): 250 - 256
    05/01/2017 Authors: Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani AB; Kucuk ON; Master VA; Gillespie TW; Filson CP
  • PET/Ultrasound fusion targeted biopsy of the prostate: initial clinical results
    Volume: 58
    05/01/2017 Authors: Fei B; Nieh P; Master V; Alemozaffar M; Tade F; Akin-Akintayo O; Osunkoya A; Goodman M; Schuster D
  • LAPAROSCOPIC RENAL CRYOABLATION USING REAL-TIME INTRAOPERATIVE THERMAL MONITORING: 15 YEAR EXPERIENCE
    Volume: 197 Page(s): E1336 - E1337
    04/01/2017 Authors: Laganosky D; Henry M; Kim F; Nieh P; Master V; Pattaras J
  • PERSONALIZED DECISION SUPPORT FOR LOCALIZED PROSTATE CANCER: RESULTS OF A MULTI-SITE RANDOMIZED TRIAL
    Volume: 197 Page(s): E122 - E122
    04/01/2017 Authors: Berry D; Hong F; Blonquist T; Halpenny B; Sanda M; Master V; Filson C; Rossi P; Chang P; Chien G
  • REEXAMINING THE ROLE OF EXTENDED LYMPHADENECTOMY FOR THE MANAGEMENT OF RENAL MALIGNANCY IN THE TARGETED THERAPY ERA
    Volume: 197 Page(s): E183 - E183
    04/01/2017 Authors: Laganosky D; Filson C; Patil D; Master V
  • A PATIENT-CENTERED PRACTICE CHANGE: FINDING THE BEST APPROACH FOR PROSTATE CANCER DECISION SUPPORT
    Volume: 197 Page(s): E933 - E933
    04/01/2017 Authors: Berry D; Halpenny B; Underhill M; Sanda M; Master V; Filson C; Chang P; Chien G; Wolpin S
  • Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    J Nucl Med Volume: 58 Page(s): 412 - 418
    03/01/2017 Authors: Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • Biomarker study of early death in patients with intermediate and favorable risk metastatic renal cell carcinoma.
    Volume: 35
    02/20/2017 Authors: Harris W; Zhang C; Liu Y; Kucuk O; Carthon BC; Master VA
  • Retrospective review of cytotoxic chemotherapy and anti-angiogenic combinations in renal cell carcinoma: A single institution experience.
    Volume: 35
    02/20/2017 Authors: Carthon BC; Tabba M; Ellis C; Harris W; Bilen MA; Canter D
  • Correlation between inflammatory markers in blood and expression of costimulatory molecules on tumor-infiltrating CD8+lymphocytes in renal cell carcinoma.
    Volume: 35
    02/20/2017 Authors: Kissick HT; Kim KS; Chang YM; Master VA
  • Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States.
    Volume: 100 Page(s): 20 - 26
    02/01/2017 Authors: David SA; Patil D; Alemozaffar M; Issa MM; Master VA; Filson CP
  • The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.
    Volume: 123 Page(s): 512 - 520
    02/01/2017 Authors: Jegadeesh N; Liu Y; Zhang C; Zhong J; Cassidy RJ; Gillespie T; Kucuk O; Rossi P; Master VA; Alemozaffar M
  • Molecular imaging and fusion targeted biopsy of the prostate.
    Clin Transl Imaging Volume: 5 Page(s): 29 - 43
    02/01/2017 Authors: Fei B; Nieh PT; Master VA; Zhang Y; Osunkoya AO; Schuster DM
  • Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Volume: 97 Page(s): 229A - 229A
    02/01/2017 Authors: Harris WB; Kucuk O; Carthon BC; Gillespie TW; Master VA; Osunkoya AO
  • Prognostic Biomarkers of Systemic Inflammation in Patients with Metastatic Renal Cell Carcinoma
    Volume: 30 Page(s): 229A - 229A
    02/01/2017 Authors: Harris WB; Kucuk O; Carthon BC; Gillespie TW; Master VA; Osunkoya AO
  • Correlation Between Programmed Death-1 Expression in Tumor Infiltrating Lymphocytes of Matched Primary and Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) and Primary Non-Metastatic CCRCC: An Analysis of 85 Cases with Emphasis on Potential Pitfalls
    Volume: 97 Page(s): 221A - 221A
    02/01/2017 Authors: DiMarco M; Patil D; Sekar RR; Master VA; Osunkoya AO
  • Automatic segmentation of the prostate on CT images using deep learning and multi-atlas fusion.
    Proc SPIE Int Soc Opt Eng Volume: 10133
    02/01/2017 Authors: Ma L; Guo R; Zhang G; Tade F; Schuster DM; Nieh P; Master V; Fei B
  • Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
    Bone Marrow Transplant Volume: 52 Page(s): 132 - 134
    01/01/2017 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Al-Kadhimi Z; Cohen JB; Flowers CR
  • Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.
    Clin Nucl Med Volume: 42 Page(s): e22 - e28
    01/01/2017 Authors: Akin-Akintayo OO; Jani AB; Odewole O; Tade FI; Nieh PT; Master VA; Bellamy LM; Halkar RK; Zhang C; Chen Z
  • Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.
    Curr Urol Rep Volume: 18 Page(s): 8
    01/01/2017 Authors: Laganosky DD; Filson CP; Master VA
  • Role of Imaging in the Evaluation of Male Infertility.
    Radiographics Volume: 37 Page(s): 837 - 854
    01/01/2017 Authors: Mittal PK; Little B; Harri PA; Miller FH; Alexander LF; Kalb B; Camacho JC; Master V; Hartman M; Moreno CC
  • Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
    J Surg Oncol Volume: 114 Page(s): 764 - 768
    11/01/2016 Authors: Mager R; Daneshmand S; Evans CP; Palou J; Martnez-Salamanca JI; Master VA; McKiernan JM; Libertino JA; Haferkamp A; International Renal Cell Carcinoma-Venous Thrombus Consortium
  • Surgical Management of Primary Scrotal Cancer.
    Urol Clin North Am Volume: 43 Page(s): 531 - 544
    11/01/2016 Authors: Huang JH; Broggi M; Osunkoya AO; Master VA
  • TECHNOLOGY SOLUTIONS? SIMPLER. CLINICAL IMPLEMENTATION IN PHYSICALLY FRAIL OLDER ADULTS? INVOLVED.
    GERONTOLOGIST Volume: 56 Page(s): 667 - 667
    11/01/2016 Authors: Vandenberg A; Johnson TM; Jones B; Clevenger C; Nadel L; Vaughan CP; Master V; Perkins M
  • Author Reply.
    Urology Volume: 96 Page(s): 105
    10/01/2016 Authors: Broggi MS; Patil D; Baum Y; Nieh PT; Alemozaffar M; Pattaras JG; Ogan K; Master VA
  • Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma.
    Urology Volume: 96 Page(s): 99 - 105
    10/01/2016 Authors: Broggi MS; Patil D; Baum Y; Nieh PT; Alemozaffar M; Pattaras JG; Ogan K; Master VA
  • Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S93 - S94
    10/01/2016 Authors: Zhong J; Switchenko J; Jegadeesh N; Gillespie TW; Master VA; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP
  • Patient Frailty and Discharge Disposition after Radical Cystectomy
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 223 Page(s): S161 - S162
    10/01/2016 Authors: Pearl J; Patil D; Arya S; Alemozaffar M; Master VA; Ogan K
  • Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Eur J Nucl Med Mol Imaging Volume: 43 Page(s): 1773 - 1783
    09/01/2016 Authors: Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O
  • Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): 78 - 86
    09/01/2016 Authors: Baumann BC; Bosch WR; Bahl A; Birtle AJ; Breau RH; Challapalli A; Chang AJ; Choudhury A; Daneshmand S; El-Gayed A
  • Editorial Comment.
    J Urol Volume: 196 Page(s): 546 - 547
    08/01/2016 Authors: Kirsch AJ
  • Frailty and one-year mortality in major intra-abdominal operations.
    J Surg Res Volume: 203 Page(s): 507 - 512.e1
    06/15/2016 Authors: Li JL; Henderson MA; Revenig LM; Sweeney JF; Kooby DA; Maithel SK; Master VA; Ogan K
  • Safety and Efficacy of Ureteral Stent Placement at the Bedside Using Local Anesthesia.
    Volume: 195 Page(s): 1886 - 1890
    06/01/2016 Authors: Nourparvar P; Leung A; Shrewsberry AB; Weiss AD; Patil D; Atallah H; Ogan K; Carney KJ; Master VA
  • "Everybody don't have the same stride": Clinic Staff Views on Gait Speed Measurement Applications
    Volume: 64 Page(s): S187 - S188
    05/01/2016 Authors: Vandenberg AE; Johnson TM; Clevenger CK; Nadel L; Perkins M; Vaughan C; Master V; Jones BD
  • Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.
    Clin Genitourin Cancer Volume: 14 Page(s): e171 - e175
    04/01/2016 Authors: Harlow BL; Klaassen Z; Holzman S; Reinstatler L; Franken AA; Kavuri SK; Terris MK; Master VA; Moses KA
  • EXTERNAL VALIDATION OF PREOPERATIVE AST/ALT (DE-RITIS) RATIO AS A PROGNOSTIC INDICATOR IN LOCALIZED AND METASTATIC RENAL CELL CARCINOMA
    Volume: 195 Page(s): E967 - E967
    04/01/2016 Authors: Patil D; Sekar R; Pearl J; Baum Y; Wehrmeyer K; Torlak M; Alemozaffar M; Filson C; Ogan K; Master V
  • THE RELATIONSHIP BETWEEN PREOPERATIVE C - REACTIVE PROTEIN AND FUHRMAN NUCLEAR GRADE IN STAGE T1 RENAL CELL CARCINOMA
    Volume: 195 Page(s): E1033 - E1033
    04/01/2016 Authors: Sekar R; Patil D; Pearl J; Baum Y; Spetka S; Alemozaffar M; Filson C; Pattaras J; Ogan K; Master V
  • EVALUATION OF TUMOR PD-1 EXPRESSION AS A PROGNOSTIC BIOMARKER IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
    Volume: 195 Page(s): E1161 - E1162
    04/01/2016 Authors: Kim K; Sekar R; DiMarco M; Petit D; Osunkoya A; Sica G; Kissick H; Pollack B; Master V
  • BLOOD SAMPLING FOR LIQUID BIOPSY OF RENAL CELL CARCINOMA OVERCOMES SAMPLING ERROR ASSOCIATED WITH BIOPSY FOR MOLECULAR GENOTYPING
    Volume: 195 Page(s): E915 - E915
    04/01/2016 Authors: Keith C; Lian F; Arnold R; Rossi M; Osunkoya A; Goecks J; Gaspar J; Ogan K; Pattaras J; Master V
  • FRAIL PATIENTS ARE LESS LIKELY TO BE DISCHARGED TO HOME AFTER CYSTECTOMY
    Volume: 195 Page(s): E71 - E72
    04/01/2016 Authors: Pearl J; Patil D; Arya S; Alemozaffar M; Master V; Ogan K
  • DELAYED TREATMENT OF HIGH-RISK PROSTATE CANCER PATIENTS: IMPACT OF SOCIOECONOMIC BARRIERS AND USE OF ADVANCED TECHNOLOGIES
    Volume: 195 Page(s): E499 - E499
    04/01/2016 Authors: Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani A; Kucuk O; Master V; Gillespie T; Filson C
  • Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival.
    Asian J Urol Volume: 3 Page(s): 75 - 81
    04/01/2016 Authors: Sekar RR; De La Calle CM; Patil D; Holzman SA; Baum Y; Sheikh U; Huang JH; Osunkoya AO; Pollack BP; Kissick HT
  • UROLOGIST USE OF CYSTOSCOPY FOR PATIENTS PRESENTING WITH HEMATURIA
    Volume: 195 Page(s): E503 - E503
    04/01/2016 Authors: David S; Petil D; Alemozaffar M; Issa M; Master V; Filson C
  • Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases.
    Hum Pathol Volume: 49 Page(s): 83 - 89
    03/01/2016 Authors: Nwadei IU; Lorentz A; Patil D; Dimarco MA; Master VA; Osunkoya AO
  • The importance of surgical margins in renal cell and urothelial carcinomas.
    J Surg Oncol Volume: 113 Page(s): 316 - 322
    03/01/2016 Authors: Alemozaffar M; Filson CP; Master VA
  • High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Previously Treated Germ Cell Tumors: A Single-Center Experience
    Volume: 22 Page(s): S421 - S422
    03/01/2016 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Waller EK
  • Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images.
    Proc SPIE Int Soc Opt Eng Volume: 9786
    02/27/2016 Authors: Ma L; Guo R; Tian Z; Venkataraman R; Sarkar S; Liu X; Nieh PT; Master VV; Schuster DM; Fei B
  • Potential Pitfalls in the Utility of Programmed Death-1 Expression in the Prediction of Prognosis in Patients with Metastatic and Non-Metastatic Clear Cell Renal Cell Carcinoma: An Analysis of 72 Cases
    Volume: 96 Page(s): 226A - 226A
    02/01/2016 Authors: DiMarco M; Sekar RR; Patil D; Master VA; Osunkoya AO
  • Potential Pitfalls in the Utility of Programmed Death-1 Expression in the Prediction of Prognosis in Patients with Metastatic and Non-Metastatic Clear Cell Renal Cell Carcinoma: An Analysis of 72 Cases
    Volume: 29 Page(s): 226A - 226A
    02/01/2016 Authors: DiMarco M; Sekar RR; Patil D; Master VA; Osunkoya A
  • External validation of preoperative AST/ALT (De-Ritis) ratio as a prognostic indicator in localized and metastatic renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Patil DH; Sekar RR; Pearl J; Baum Y; Alemozaffar M; Filson CP; Ogan K; Master VA
  • A novel preoperative inflammatory marker prognostic score in patients with clear cell and non-clear cell renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Sekar RR; Patil D; Pearl J; Baum Y; Kucuk O; Harris WB; Carthon B; Alemozaffar M; Filson CP; Ogan K
  • The relationship between preoperative c-reactive protein and Fuhrman nuclear grade in stage T1 renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Sekar RR; Patil D; Pearl J; Baum Y; Alemozaffar M; Filson CP; Ogan K; Master VA
  • Nephrectomy status, race, and overall survival in patients with metastatic renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Robertson DK; Zhang C; Liu Y; Gillespie TW; Kucuk O; Carthon BC; Master VA; Issa M; Petros J; Harris WB
  • Dynamic correlation of serum C-reactive protein (CRP) levels with serum prostate-specific antigen (PSA) levels in patients with prostate cancer (PCa) on androgen deprivation therapy (ADT).
    Volume: 34
    01/10/2016 Authors: Kucuk O; Balci B; Liu Y; Zhang C; Yilmaz B; Atag E; Karaoglu A; Jani AB; Harris W; Carthon BC
  • PD-1 expression and its impact on survival in localized clear cell renal cell carcinoma
    Volume: 34
    01/10/2016 Authors: Sekar RR; DiMarco MA; Patil D; Osunkoya AO; Pollack BP; Sica G; Master VA
  • Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer
    Volume: 34
    01/10/2016 Authors: Baumann BC; Bosch W; Bahl A; Birtle AJ; Breau RH; Challapalli A; Chang A; Choudhury A; Daneshmand S; Feldman AS
  • The role of adjuvant radiotherapy in pathologically node positive prostate cancer
    Volume: 34
    01/10/2016 Authors: Jegadeesh N; Liu Y; Zhang C; Zhong J; Gillespie TW; Kucuk O; Rossi PJ; Master VA; Alemozaffar M; Jani AB
  • Hematospermia Evaluation at MR Imaging.
    Radiographics Volume: 36 Page(s): 1373 - 1389
    01/01/2016 Authors: Mittal PK; Camacho JC; Sahani DV; Kalb B; Harri PA; Master V; Kokabi N; Hartman M; Kitajima HD; Moreno CC
  • Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
    Asian J Urol Volume: 3 Page(s): 20 - 25
    01/01/2016 Authors: Baum YS; Patil D; Huang JH; Spetka S; Torlak M; Nieh PT; Alemozaffar M; Ogan K; Master VA
  • C-reactive protein in urologic cancers.
    Mol Aspects Med Volume: 45 Page(s): 28 - 36
    11/01/2015 Authors: Huang J; Baum Y; Alemozaffar M; Ogan K; Harris W; Kucuk O; Master VA
  • Impact of Anti-3-[18F]FACBC Positron Emission Tomography on Target Volume Definition After Prostatectomy: Initial Findings From a Randomized Trial
    Volume: 93 Page(s): S135 - S135
    11/01/2015 Authors: Jani A; Schreibmann E; Rossi PJ; Shelton JW; Godette KD; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • Development and Validation of Contouring Guidelines for Postcystectomy Adjuvant Radiation of Bladder Cancer
    Volume: 93 Page(s): S24 - S25
    11/01/2015 Authors: Christodouleas JP; Baumann BC; Bosch WR; Bahl A; Birtle A; Breau R; Challapalli A; Chang AJ; Choudhury A; Daneshmand S
  • Predicting Length of Stay Following Radical Nephrectomy Using the National Surgical Quality Improvement Program Database.
    J Urol Volume: 194 Page(s): 923 - 928
    10/01/2015 Authors: Lorentz CA; Leung AK; DeRosa AB; Perez SD; Johnson TV; Sweeney JF; Master VA
  • A new inflammatory-based marker prognostic score in a large cohort of patients with localized clear cell renal cell carcinoma
    Volume: 221 Page(s): E147 - E147
    10/01/2015 Authors: Baum YS; Patil D; Huang JH; Bausum A; Ogan K; Master VA
  • Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.
    J Urol Volume: 194 Page(s): 304 - 308
    08/01/2015 Authors: Nguyen HG; Tilki D; Dall'Era MA; Durbin-Johnson B; Carballido JA; Chandrasekar T; Chromecki T; Ciancio G; Daneshmand S; Gontero P
  • Kinetic risk assessment with biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma
    Volume: 75
    08/01/2015 Authors: Harris WB; Kucuk O; Carthon B; Liu Y; Pattaras J; Ogan K; Master V
  • Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.
    Can J Urol Volume: 22 Page(s): 7783 - 7787
    06/01/2015 Authors: Fatima N; Canter DJ; Carthon BC; Kucuk O; Master VA; Nieh PT; Ogan K; Osunkoya AO
  • Characterization and survival of patients presenting with PSA values 100 or greater.
    Volume: 33
    05/20/2015 Authors: Leung AK; Hugar L; Patil D; Wong L; Carthon BC; Moses KA; Master VA
  • Extramammary Paget's disease in males: survival outcomes in 495 patients.
    Ann Surg Oncol Volume: 22 Page(s): 1625 - 1630
    05/01/2015 Authors: Herrel LA; Weiss AD; Goodman M; Johnson TV; Osunkoya AO; Delman KA; Master VA
  • R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    J Vasc Interv Radiol Volume: 26 Page(s): 686 - 693
    05/01/2015 Authors: Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
  • Report of a Simplified Frailty Score Predictive of Short-Term Postoperative Morbidity and Mortality.
    J Am Coll Surg Volume: 220 Page(s): 904 - 11.e1
    05/01/2015 Authors: Revenig LM; Canter DJ; Kim S; Liu Y; Sweeney JF; Sarmiento JM; Kooby DA; Maithel SK; Hill LL; Master VA
  • Change in salvage radiotherapy management based on guidance with anti-3-[F-18] FACBC PET-CT in recurrent prostate cancer patients post-prostatectomy.
    Volume: 56
    05/01/2015 Authors: Odewole O; Jani A; Tade F; Nieh P; Master V; Bellamy M; Goodman M; Halkar R; Schuster D
  • Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.
    Volume: 572 Page(s): 36 - 39
    04/15/2015 Authors: Sahin K; Cross B; Sahin N; Ciccone K; Suleiman S; Osunkoya AO; Master V; Harris W; Carthon B; Mohammad R
  • Reproducibility and reliability of anti-3-[F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis.
    Mol Imaging Biol Volume: 17 Page(s): 277 - 283
    04/01/2015 Authors: Odewole OA; Oyenuga OA; Tade F; Savir-Baruch B; Nieh PT; Master V; Chen Z; Wang X; Jani AB; Bellamy LM
  • COMMONLY-USED COST-EFFECTIVE PRE-OPERATIVE INFLAMMATORY MARKERS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
    Volume: 193 Page(s): E424 - E424
    04/01/2015 Authors: Baum Y; De la Calle C; Patil D; Bausum A; Huang J; Alemozaffar M; Pattaras J; Nieh P; Ogan K; Master V
  • PRE-OPERATIVE MODIFIED GLASGOW PROGNOSTIC SCORE AS AN INDEPENDENT PROGNOSIS FACTOR IN A LARGE US POPULATION
    Volume: 193 Page(s): E529 - E529
    04/01/2015 Authors: Baum Y; De la Calle C; Patil D; Schwartz R; Huang J; Ogan K; Alemozaffar M; Pattaras J; Nieh P; Master V
  • Video-based educational tool improves patient comprehension of common prostate health terminology.
    Volume: 121 Page(s): 733 - 740
    03/01/2015 Authors: Wang DS; Jani AB; Sesay M; Tai CG; Lee DK; Echt KV; Goodman MG; Kilbridge KE; Master VA
  • Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
    Int J Urol Volume: 22 Page(s): 264 - 270
    03/01/2015 Authors: Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
  • Outcomes data in pain studies: in reply to Barbul and colleagues.
    J Am Coll Surg Volume: 220 Page(s): 375
    03/01/2015 Authors: Master VA; Watkins AA; Johnson TV; Shrewsberry AB; Nourparvar P; Madni T; Watkins CJ; Feingold PL; Kooby DA; Maithel SK
  • Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer.
    J Natl Compr Canc Netw Volume: 13 Page(s): 303 - 309
    03/01/2015 Authors: Quek RGW; Ward KC; Master VA; Lin CC; Portier KM; Virgo KS; Lipscomb J
  • Evaluation of major histocompatibility complex class I expression in clear cell renal cell carcinoma as a prognostic tool
    Volume: 33
    03/01/2015 Authors: de la Calle CM; Holzman SA; Sheikh U; Huang JH; Kissick HT; Osunkoya AO; Pollack BP; Patil D; Ogan K; Master VA
  • Preoperative quantification of perceptions of surgical frailty.
    J Surg Res Volume: 193 Page(s): 583 - 589
    02/01/2015 Authors: Revenig LM; Canter DJ; Henderson MA; Ogan K; Kooby DA; Maithel SK; Liu Y; Kim S; Master VA
  • Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
    J Urol Volume: 193 Page(s): 436 - 442
    02/01/2015 Authors: Tilki D; Hu B; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chandrasekar T; Chromecki T; Ciancio G; Daneshmand S
  • Surgery for high-risk prostate cancer and metastatic prostate cancer.
    Curr Probl Cancer Volume: 39 Page(s): 33 - 40
    01/01/2015 Authors: Safir IJ; Lian F; Alemozaffar M; Master VA
  • High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis.
    Urol Int Volume: 95 Page(s): 72 - 78
    01/01/2015 Authors: Holzman SA; de la Calle CM; Kissick HT; Osunkoya AO; Pollack BP; Patil D; Ogan K; Master VA
  • Testicular tumors: what radiologists need to know--differential diagnosis, staging, and management.
    Radiographics Volume: 35 Page(s): 400 - 415
    01/01/2015 Authors: Coursey Moreno C; Small WC; Camacho JC; Master V; Kokabi N; Lewis M; Hartman M; Mittal PK
  • Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results.
    J Immunother Cancer Volume: 3 Page(s): 14
    01/01/2015 Authors: Amin A; Dudek AZ; Logan TF; Lance RS; Holzbeierlein JM; Knox JJ; Master VA; Pal SK; Miller WH; Karsh LI
  • von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry.
    J Urol Volume: 192 Page(s): 1528 - 1533
    11/01/2014 Authors: Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Petros JA
  • Inflammation-free survival as a surrogate endpoint for overall survival in patients with metastatic renal cell carcinoma
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Volume: 23
    11/01/2014 Authors: Harris WB; Nickleach DC; Liu Y; Kucuk O; Master VA
  • Eye of the beholder?: A prospective study examining the correlation between patients' and surgeons' subjective assessment of surgical frailty
    Volume: 219 Page(s): E18 - E18
    10/01/2014 Authors: Canter DJ; Revenig L; Ogan K; Kooby DA; Maithel S; Sweeney JF; Sarmiento JM; Liu Y; Kim S; Master VA
  • Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Eur Urol Volume: 66 Page(s): 577 - 583
    09/01/2014 Authors: Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J
  • Ice packs reduce postoperative midline incision pain and narcotic use: a randomized controlled trial.
    J Am Coll Surg Volume: 219 Page(s): 511 - 517
    09/01/2014 Authors: Watkins AA; Johnson TV; Shrewsberry AB; Nourparvar P; Madni T; Watkins CJ; Feingold PL; Kooby DA; Maithel SK; Staley CA
  • Evaluation of the Safety and Quality of Videoscopic Inguinal Lymphadenectomy: Mitigation of Patient Comorbidities by a Minimally Invasive Technique
    Volume: 219 Page(s): S124 - S124
    09/01/2014 Authors: Squires MH; Master VA; Kooby DA; Russell MC; Rizzo M; Ogan K; Martin BM; Longwell AB; Carlson GW; Delman KA
  • Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer.
    Urol Oncol Volume: 32 Page(s): 748 - 760
    08/01/2014 Authors: Quek RGW; Master VA; Portier KM; Ward KC; Lin CC; Virgo KS; Lipscomb J
  • Leaning in to understand hospital readmission.
    J Urol Volume: 192 Page(s): 10 - 12
    07/01/2014 Authors: Master VA
  • Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
    J Urol Volume: 191 Page(s): 1665 - 1670
    06/01/2014 Authors: King SC; Pollack LA; Li J; King JB; Master VA
  • Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990-2009.
    Am J Public Health Volume: 104 Suppl 3 Page(s): S396 - S403
    06/01/2014 Authors: Li J; Weir HK; Jim MA; King SM; Wilson R; Master VA
  • Long-term survival in unfavorable-risk mRCC patients treated with a combination of autologous immunotherapy (AGS-003) plus sunitinib.
    Volume: 32
    05/20/2014 Authors: Amin A; Dudek AZ; Logan TF; Lance RS; Holzbeierlein JM; Master VA; Pal SK; Knox JJ; Karsh LI; Plessinger D
  • Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.
    J Urol Volume: 191 Page(s): 1446 - 1453
    05/01/2014 Authors: Schuster DM; Nieh PT; Jani AB; Amzat R; Bowman FD; Halkar RK; Master VA; Nye JA; Odewole OA; Osunkoya AO
  • Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
    Curr Urol Rep Volume: 15 Page(s): 404
    05/01/2014 Authors: Martnez-Salamanca JI; Linares E; Gonzlez J; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Evans CP; Gontero P
  • Anti-1-amino-3-[18F] fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC): Normal physiology and variant patterns of uptake
    Volume: 55
    05/01/2014 Authors: Savir-Baruch B; Odewole O; Nye J; Master V; Nieh P; Jani A; Bellamy M; Halkar R; Goodman M; Schuster D
  • Reproducibility of anti-3-[18F]FACBC uptake in background structures and malignant lesions on followup PET-CT in prostate carcinoma: An exploratory analysis
    Volume: 55
    05/01/2014 Authors: Odewole O; Savir-Baruch B; Nieh P; Master V; Chen Z; Wang X; Jani A; Halkar R; Goodman M; Schuster D
  • A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery.
    J Endourol Volume: 28 Page(s): 476 - 480
    04/01/2014 Authors: Revenig LM; Canter DJ; Master VA; Maithel SK; Kooby DA; Pattaras JG; Tai C; Ogan K
  • Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma.
    J Am Coll Surg Volume: 218 Page(s): 620 - 626
    04/01/2014 Authors: Martin BM; Etra JW; Russell MC; Rizzo M; Kooby DA; Staley CA; Master VA; Delman KA
  • Designing an ethics curriculum to support global health experiences in surgery.
    J Surg Res Volume: 187 Page(s): 367 - 370
    04/01/2014 Authors: Martin BM; Love TP; Srinivasan J; Sharma J; Pettitt B; Sullivan C; Pattaras J; Master VA; Brewster LP
  • VON HIPPEL-LINDAU EXONIC METHYLATION ANALYSIS USING MALDI-TOF MASS SPECTROMETRY
    Volume: 191 Page(s): E248 - E249
    04/01/2014 Authors: Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Ressler K; Petros JA
  • MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMA: CORRELATION WITH CLINICAL OUTCOME
    Volume: 191 Page(s): E379 - E380
    04/01/2014 Authors: Holzman S; Osunkoya A; Pollack B; Ogan K; Master V
  • Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.
    Clin Transplant Volume: 28 Page(s): 211 - 216
    02/01/2014 Authors: Shrewsberry AB; Osunkoya AO; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master VA; Ogan K
  • Evaluation and management of patients with nocturia.
    JAAPA Volume: 27 Page(s): 36 - 42
    02/01/2014 Authors: Easterling SA; Master V; Carney KJ
  • Major Histocompatibility Complex Class I Expression in Clear Cell Renal Cell Carcinoma: Correlation with Clinical Outcome
    Volume: 27 Page(s): 235A - 235A
    02/01/2014 Authors: Holzman SA; Pollack BP; Master VA; Osunkoya AO
  • Major Histocompatibility Complex Class I Expression in Clear Cell Renal Cell Carcinoma: Correlation with Clinical Outcome
    Volume: 94 Page(s): 235A - 235A
    02/01/2014 Authors: Holzman SA; Pollack BP; Master VA; Osunkoya AO
  • Major histocompatibility complex class I (MHC 1) expression in clear cell renal cell carcinoma: Correlation with clinical outcome.
    Volume: 32
    02/01/2014 Authors: Master VA; Holzman S; Pollack B; Osunkoya AO
  • External validation of the modified Glasgow prognostic score for renal cancer.
    Indian J Urol Volume: 30 Page(s): 33 - 37
    01/01/2014 Authors: Tai CG; Johnson TV; Abbasi A; Herrell L; Harris WB; Kucuk O; Canter DJ; Ogan K; Pattaras JG; Nieh PT
  • Numeracy among trainees: are we preparing physicians for evidence-based medicine?
    J Surg Educ Volume: 71 Page(s): 211 - 215
    01/01/2014 Authors: Johnson TV; Abbasi A; Schoenberg ED; Kellum R; Speake LD; Spiker C; Foust A; Kreps A; Ritenour CWM; Brawley OW
  • Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
    Dis Markers Volume: 2014 Page(s): 135649
    01/01/2014 Authors: Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
  • Digging deep: high output heart failure in renal cell carcinoma.
    Am J Med Volume: 127 Page(s): 22 - 24
    01/01/2014 Authors: Hayek S; Kung R; Barb I; Master V; Al S; Clements S
  • Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer.
    Cancer Volume: 119 Page(s): 3619 - 3628
    10/15/2013 Authors: Quek RGW; Master VA; Ward KC; Lin CC; Virgo KS; Portier KM; Lipscomb J
  • Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes.
    J Am Coll Surg Volume: 217 Page(s): 665 - 670.e1
    10/01/2013 Authors: Revenig LM; Canter DJ; Taylor MD; Tai C; Sweeney JF; Sarmiento JM; Kooby DA; Maithel SK; Master VA; Ogan K
  • Videoscopic inguinal lymphadenectomy for metastatic melanoma.
    Cancer Control Volume: 20 Page(s): 255 - 260
    10/01/2013 Authors: Martin BM; Master VA; Delman KA
  • Minimizing morbidity in melanoma surgery.
    Oncology (Williston Park) Volume: 27 Page(s): 1016 - 1020
    10/01/2013 Authors: Martin BM; Master VA; Delman KA
  • Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.
    Can J Urol Volume: 20 Page(s): 6915 - 6921
    10/01/2013 Authors: Canter DJ; Mallin K; Uzzo RG; Egleston BL; Simhan J; Walton J; Smaldone MC; Master VA; Bratslavsky G; Kutikov A
  • The Role of the Urologist in Whether Locoregional Prostate Cancer Patients Consult With a Radiation Oncologist
    Volume: 87 Page(s): S485 - S486
    10/01/2013 Authors: Quek RGW; Ward KC; Master VA; Lin CC; Virgo KS; Portier KM; Lipscomb J
  • Determinants of the Combined Use of External Beam Radiation Therapy and Brachytherapy for Low-Risk Localized Prostate Cancer
    Volume: 87 Page(s): S484 - S485
    10/01/2013 Authors: Quek RGW; Master VA; Ward KC; Lin CC; Virgo KS; Portier KM; Lipscomb J
  • The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate.
    Cancer Volume: 119 Page(s): 3272 - 3279
    09/15/2013 Authors: Hall WA; Nickleach DC; Master VA; Prabhu RS; Rossi PJ; Godette K; Cooper S; Jani AB
  • Severe lack of comprehension of common prostate health terms among low-income inner-city men.
    Cancer Volume: 119 Page(s): 3204 - 3211
    09/01/2013 Authors: Wang DS; Jani AB; Tai CG; Sesay M; Lee DK; Goodman M; Echt KV; Kilbridge KE; Master VA
  • Ice packs reduce postoperative pain and narcotic use in patients with midline abdominal incisions: a randomized controlled trial
    Volume: 217 Page(s): S131 - S131
    09/01/2013 Authors: Abbasi A; Johnson TV; Shrewsberry AB; Madni T; Bhatti A; Watkins CJ; Kooby DA; Staley CA; Maithel SK; Master VA
  • Inherent difficulties of measuring the burden of surgical disease in resource-poor settings.
    World J Surg Volume: 37 Page(s): 2248 - 2249
    09/01/2013 Authors: Leeds IL; Hugar LA; Lorentz CA; Srinivasan J; Pattaras JG; Master VA
  • Initial experience assessing pre-operative frailty with patients undergoing radical cystectomy for urothelial cancer
    Volume: 217 Page(s): S146 - S147
    09/01/2013 Authors: Revenig LM; Tai CG; Taylor MD; Master VA; Ogan K; Canter DJ
  • Long-term oncological follow-up on laparoscopic cryoablation of renal masses with intra-operative temperature monitoring
    Volume: 217 Page(s): S151 - S151
    09/01/2013 Authors: Bui D; Pattaras JG; Master VA; Nieh PT
  • International surgical clerkship rotation: perceptions and academic performance.
    Am J Surg Volume: 206 Page(s): 280 - 286
    08/01/2013 Authors: Leeds IL; Hugar LA; Pettitt BJ; Srinivasan J; Master VA
  • Assessment of single-item literacy questions, age, and education level in the prediction of low health numeracy.
    JAAPA Volume: 26 Page(s): 50 - 54
    08/01/2013 Authors: Johnson TV; Abbasi A; Kleris RS; Ehrlich SS; Barthwaite E; DeLong J; Master VA
  • Racial disparities in prostate cancer care: is adherence to National Comprehensive Cancer Network guidelines good enough for our patients?
    Cancer Volume: 119 Page(s): 2209 - 2211
    06/15/2013 Authors: Master VA; Moses KA
  • Scrotal cancer survival is influenced by histology: a SEER study.
    World J Urol Volume: 31 Page(s): 585 - 590
    06/01/2013 Authors: Johnson TV; Hsiao W; Delman KA; Canter DJ; Master VA
  • Systematic review of the evidence of a relationship between chronic psychosocial stress and C-reactive protein.
    Mol Diagn Ther Volume: 17 Page(s): 147 - 164
    06/01/2013 Authors: Johnson TV; Abbasi A; Master VA
  • Clinical utility of biomarkers of systemic inflammation for patients with metastatic renal cell carcinoma.
    Volume: 31
    05/20/2013 Authors: Harris W; Akbashev MY; Kucuk O; Liu Y; Hsiao W; Osunkoya AO; Baumgarten DO; Master VA
  • Determinants of the combined use of external beam radiation therapy and brachytherapy for low-risk localized prostate cancer.
    Volume: 31
    05/20/2013 Authors: Quek RGW; Master VA; Ward KC; Lin CC; Virgo KS; Portier KM; Lipscomb J
  • Role of the urologist in whether locoregional prostate cancer patients consult with a radiation oncologist.
    Volume: 31
    05/20/2013 Authors: Quek RGW; Ward KC; Master VA; Lin CC; Virgo KS; Portier KM; Lipscomb J
  • INFLUENCE OF UROLOGISTS' PRACTICE AFFILIATIONS WITH MEDICAL SCHOOLS ON THE USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATE CANCER PATIENTS IN UNITED STATES
    VALUE IN HEALTH Volume: 16 Page(s): A154 - A154
    05/01/2013 Authors: Quek RGW; Lin CC; Master VA; Virgo KS; Ward KC; Portier KM; Lipsomb J
  • Ethnic disparities in prognosis associated with persistence of the systemic inflammatory response in metastatic renal cell carcinoma.
    Volume: 73
    04/15/2013 Authors: Harris WB; Gao J; Nickleach DC; Liu Y; Kucuk O; Master V
  • SEVERE LACK OF COMPREHENSION OF COMMON PROSTATE HEALTH TERMINOLOGY IN DIVERSE POPULATIONS
    Volume: 189 Page(s): E170 - E170
    04/01/2013 Authors: Wang D; Sesay M; Tai C; Lee D; Goodman M; Echt K; Kilbridge K; Jani A; Master V
  • INITIAL EXPERIENCE ASSESSING PRE-OPERATIVE FRAILTY WITH PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CANCER
    Volume: 189 Page(s): E212 - E212
    04/01/2013 Authors: Ogan K; Taylor MD; Tai CG; Herrel LA; Cross B; Master VA; Carthon BC; Canter D
  • DEVELOPMENT OF A TEST FOR RCC BY DETECTION OF VHL MUTATIONS IN TISSUE AND FLUIDS OF PATIENTS WITH RENAL CELL CARCINOMA
    Volume: 189 Page(s): E249 - E250
    04/01/2013 Authors: Sreedharan S; Arnold RS; Kerley K; Mercer KB; Ressler K; Master VA; Ogan K; Roberts DL; Pattaras JG; Petros JA
  • Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicopathologic study of 14 cases.
    Anal Quant Cytopathol Histpathol Volume: 35 Page(s): 77 - 84
    04/01/2013 Authors: Lauer SR; Zhou M; Master VA; Osunkoya AO
  • Computed tomography based renal parenchyma volume measurements prior to renal tumor surgery are predictive of postoperative renal function.
    Can J Urol Volume: 20 Page(s): 6714 - 6720
    04/01/2013 Authors: Kunzel B; Small W; Goodman M; Pattaras J; Master V; Ogan K
  • NOMOGRAMS INCORPORATING SERUM C-REACTIVE PROTEIN (CRP) LEVELS EFFECTIVELY PREDICT MORTALITY AFTER NEPHRECTOMY.
    Volume: 189 Page(s): E306 - E307
    04/01/2013 Authors: Hsiao W; Herrel L; Yu C; Kattan M; Ogan K; Canter D; Pattaras J; Nieh P; Harris W; Carthon B
  • RENAL CELL CARCINOMA IN PATIENTS WITH END-STAGE RENAL DISEASE HAS FAVORABLE OVERALL PROGNOSIS
    Volume: 189 Page(s): E303 - E303
    04/01/2013 Authors: Shrewsberry A; Osunkoya A; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master V; Ogan K
  • Accuracy Evaluation of a 3D Ultrasound-guided Biopsy System.
    Proc SPIE Int Soc Opt Eng Volume: 8671
    03/14/2013 Authors: Wooten WJ; Nye JA; Schuster DM; Nieh PT; Master VA; Votaw JR; Fei B
  • Preoperative C-reactive protein combined with SSIGN score as an independent predictor of cancer-specific survival in patients with clear cell renal cell carcinoma.
    Volume: 31 Page(s): 451
    02/20/2013 Authors: Tai CG-L; Westby R; Ogan K; Canter D; Pattaras J; Nieh P; Master VA
  • Postoperative modified Glasgow prognostic score as an independent predictor of overall survival in clinically localized clear cell renal cell carcinoma.
    Volume: 31 Page(s): 456
    02/20/2013 Authors: Tai CG-L; Westby R; Ogan K; Canter D; Pattaras J; Nieh P; Master VA
  • Severe lack of comprehension of common prostate health terminology in underserved populations: External validation
    Volume: 31
    02/20/2013 Authors: Master VA; Wang DS-P; Tai CG-L; Sesay M; Kilbridge KL; Goodman M; Jani AB
  • Prolonged survival with personalized immunotherapy (AGS-003) in combination with sunitinib in unfavorable risk metastatic RCC (mRCC).
    Volume: 31 Page(s): 357
    02/20/2013 Authors: Dudek A; Logan T; Lance RS; Holzbeierlein JM; Master VA; Pal SK; Knox JJ; Karsh LI; Plessinger D; Nicolette CA
  • Severe lack of comprehension of common prostate health terminology in underserved populations: External validation.
    J Clin Oncol Volume: 31 Page(s): 71
    02/20/2013 Authors: Wang DS-P; Tai CG-L; Sesay M; Kilbridge KL; Goodman M; Jani AB
  • Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes.
    J Urol Volume: 189 Page(s): 702 - 710
    02/01/2013 Authors: Yang X; Shao C; Wang R; Chu C-Y; Hu P; Master V; Osunkoya AO; Kim HL; Zhau HE; Chung LWK
  • A win for all: faculty-student partnerships in surgical humanitarianism.
    Bull Am Coll Surg Volume: 98 Page(s): 12 - 17
    02/01/2013 Authors: Leeds IL; Srinivasan J; Pattaras JG; Master VA
  • Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.
    Am J Nucl Med Mol Imaging Volume: 3 Page(s): 85 - 96
    01/01/2013 Authors: Schuster DM; Taleghani PA; Nieh PT; Master VA; Amzat R; Savir-Baruch B; Halkar RK; Fox T; Osunkoya AO; Moreno CS
  • Breakage of Needle during Intracavernosal Injection and Use of Portable Ultrasound Guidance for Removal.
    Case Rep Urol Volume: 2013 Page(s): 215492
    01/01/2013 Authors: Hsiao W; Lian F; Goodgame B; Ritenour CWM; Angell J; Master VA
  • PET-directed, 3D Ultrasound-guided prostate biopsy.
    Diagn Imaging Eur Volume: 29 Page(s): 12 - 15
    01/01/2013 Authors: Fei B; Nieh PT; Schuster DM; Master VA
  • C-Reactive Protein (CRP): Initial Exploratory Study of an Inflammatory Biomarker for Prostate Cancer Radiation Therapy
    Volume: 84 Page(s): S710 - S711
    11/01/2012 Authors: Hall WA; Rossi PJ; Cooper S; Master VA; Jani AB
  • Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications.
    J Urol Volume: 188 Page(s): 1176 - 1180
    10/01/2012 Authors: Master VA; Jafri SMA; Moses KA; Ogan K; Kooby DA; Delman KA
  • COMPUTED TOMOGRAPHY BASED RENAL PARENCHYMAL VOLUME MEASUREMENTS PRIOR TO RENAL TUMOR SURGERY IS PREDICTIVE OF POSTOPERATIVE RENAL FUNCTION
    JOURNAL OF ENDOUROLOGY Volume: 26 Page(s): A241 - A242
    09/01/2012 Authors: Ogan K; Kunzel B; Small W; Goodman M; Faurot M; Pattaras J; Master V
  • Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma.
    Can J Urol Volume: 19 Page(s): 6395 - 6400
    08/01/2012 Authors: Canter DJ; Dobbs RW; Jafri SMA; Herrel LA; Ogan K; Delman KA; Master VA
  • Multi-disciplinary update on pelvic fracture associated bladder and urethral injuries.
    Injury Volume: 43 Page(s): 1242 - 1249
    08/01/2012 Authors: Figler BD; Hoffler CE; Reisman W; Carney KJ; Moore T; Feliciano D; Master V
  • Prospective pilot study of smoking cessation in patients undergoing urologic surgery.
    Urology Volume: 80 Page(s): 104 - 109
    07/01/2012 Authors: Kunzel B; Cabalza J; Faurot M; Solomon T; Nieh P; Pattaras J; Master VA; Ogan K
  • Hyperspectral imaging and quantitative analysis for prostate cancer detection.
    J Biomed Opt Volume: 17 Page(s): 076005
    07/01/2012 Authors: Akbari H; Halig LV; Schuster DM; Osunkoya A; Master V; Nieh PT; Chen GZ; Fei B
  • ASSOCIATION BETWEEN SMOKING STATUS AND FREE, TOTAL, AND PERCENT FREE PROSTATE-SPECIFIC ANTIGEN.
    Volume: 175 Page(s): S24 - S24
    06/15/2012 Authors: Li J; Thompson T; Joseph DA; Master VA
  • Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach.
    Can J Urol Volume: 19 Page(s): 6306 - 6309
    06/01/2012 Authors: Herrel LA; Butterworth RM; Jafri SM; Ying C; Delman KA; Kooby DA; Ogan KE; Canter DJ; Master VA
  • Re: Lymphangiography with sclerotherapy: a novel therapy for refractory chylous ascites.
    Can J Urol Volume: 19 Page(s): 6255
    06/01/2012 Authors: Master VA
  • Lymphangiography with sclerotherapy: a novel therapy for refractory chylous ascites EDITORIAL COMMENT
    CANADIAN JOURNAL OF UROLOGY Volume: 19 Page(s): 6255 - 6255
    06/01/2012 Authors: Master VA
  • Efficacy and tolerability of biweekly gemcitabine plus cisplatin (GEMCIS) or gemcitabine plus paclitaxel (GEMPAC) as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
    Volume: 30
    05/20/2012 Authors: Karaoglu A; Nieh P; Canter D; Master VA; Carthon B; Harris W; Shelton J; Rossi PJ; Jani AB; Khan MK
  • Extraprostatic recurrent prostate carcinoma detection with synthetic amino acid PET/CT surpasses imaging with (111)Indium-capromabpendetide plus diagnostic CT
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Amzat R; Taleghani P; Savir-Baruch B; Nieh P; Master V; Rossi P; Halkar R; Goodman M; Bowman F; Schuster D
  • Increased expression of Ki-67 correlates with synthetic amino acid PET radiotracer uptake in prostate cancer
    Volume: 53
    05/01/2012 Authors: Taleghani P; Amzat R; Osunkoya A; Savir-Baruch B; Nieh P; Master V; Fei B; Fox T; Goodman M; Schuster D
  • Synthetic amino acid PET in primary prostate carcinoma: Correlation of pre-surgical imaging with radical prostatectomy specimens
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Taleghani P; Amzat R; Osunkoya A; Savir-Baruch B; Nieh P; Master V; Fei B; Fox T; Goodman M; Schuster D
  • Feasibility of targeted lymph node removal in recurrent prostate carcinoma guided by synthetic amino acid PET: Can we decrease disease burden prior to initiation of systemic therapy?
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Savir-Baruch B; Amzat R; Taleghani P; Master V; Nieh P; Rossi P; Goodman M; Schuster D
  • Inflammatory response as a novel prognostic parameter in patients with metastatic renal cell carcinoma treated with pazopanib
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Lingerfelt BM; Akbashev MY; Master VA; Harris WB
  • MINIMALLY INVASIVE INGUINAL LYMPHADENECTOMY VIA ENDOSCOPIC GROIN DISSECTION: COMPREHENSIVE ASSESSMENT OF IMMEDIATE AND LONG-TERM COMPLICATIONS
    Volume: 187 Page(s): E376 - E376
    04/01/2012 Authors: Master VA; Jafri SMA; Herrel L; Ogan K; Kooby DA; Delman KA
  • Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology.
    Psychooncology Volume: 21 Page(s): 351 - 356
    04/01/2012 Authors: Johnson TV; Garlow SJ; Brawley OW; Master VA
  • Association between smoking status, and free, total and percent free prostate specific antigen.
    J Urol Volume: 187 Page(s): 1228 - 1233
    04/01/2012 Authors: Li J; Thompson T; Joseph DA; Master VA
  • Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors.
    Can J Urol Volume: 19 Page(s): 6211 - 6216
    04/01/2012 Authors: Canter DJ; Ogan K; Master VA
  • EXTERNAL VALIDATION OF THE MODIFIED GLASGOW PROGNOSTIC SCORE (MGPS) FOR RENAL CANCER
    Volume: 187 Page(s): E680 - E680
    04/01/2012 Authors: Cross B; Johnson T; Kucuk O; Canter D; Pattaras J; Ogan K; Nieh P; Harris W; Master V
  • Duplicated vena cava with tumor thrombus from renal cancer: use of venogram for safer operative planning.
    Urology Volume: 79 Page(s): e57 - e58
    04/01/2012 Authors: Abbasi A; Johnson TV; Ying K; Baumgarten D; Millner R; Master VA
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    02/10/2012 Authors: Akbashev MY; Lingerfelt BM; Liu Y; Kucuk O; Master VA; Harris W
  • Phase II study combining personalized dendritic cell (DC)-based therapy, AGS-003, with sunitinib in metastatic renal cell carcinoma (mRCC).
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    02/10/2012 Authors: Figlin RA; Amin A; Dudek A; Logan T; Lance RS; Holzbeierlein JM; Master VA; Pal SK; Gamble AH; DeBenedette M
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    J Clin Oncol Volume: 30 Page(s): 378
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents.
    J Clin Oncol Volume: 30 Page(s): 441
    02/10/2012 Authors: Akbashev MY; Lingerfelt BM; Liu Y; Kucuk O; Master VA; Harris W
  • Phase II study combining personalized dendritic cell (DC)-based therapy, AGS-003, with sunitinib in metastatic renal cell carcinoma (mRCC).
    J Clin Oncol Volume: 30 Page(s): 348
    02/10/2012 Authors: Figlin RA; Amin A; Dudek A; Logan T; Lance RS; Holzbeierlein JM; Master VA; Pal SK; Gamble AH; DeBenedette M
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    J Clin Oncol Volume: 30 Page(s): 378
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents.
    J Clin Oncol Volume: 30 Page(s): 441
    02/10/2012 Authors: Akbashev MY; Lingerfelt BM; Liu Y; Kucuk O; Master VA; Harris W
  • Phase II study combining personalized dendritic cell (DC)-based therapy, AGS-003, with sunitinib in metastatic renal cell carcinoma (mRCC).
    J Clin Oncol Volume: 30 Page(s): 348
    02/10/2012 Authors: Figlin RA; Amin A; Dudek A; Logan T; Lance RS; Holzbeierlein JM; Master VA; Pal SK; Gamble AH; DeBenedette M
  • IPSS quality of life question: a possible indicator of depression among patients with lower urinary tract symptoms.
    Can J Urol Volume: 19 Page(s): 6100 - 6104
    02/01/2012 Authors: Johnson TV; Abbasi A; Ehrlich SS; Kleris RS; Owen-Smith A; Raison CL; Master VA
  • Sensitive biomarkers of cancer recurrence and metastasis: inexpensive tools to cut costs and reduce radiation exposure among cancer patients.
    Mol Diagn Ther Volume: 16 Page(s): 13 - 14
    02/01/2012 Authors: Johnson TV; Master VA
  • Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications.
    J Urol Volume: 187 Page(s): 296 - 301
    01/01/2012 Authors: Abbasi A; Johnson TV; Kleris R; Ying K; Bonner MY; Maithel SK; Kooby DA; Marshall FF; Master VA
  • Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007.
    Prostate Cancer Volume: 2012 Page(s): 691380
    01/01/2012 Authors: Li J; Djenaba JA; Soman A; Rim SH; Master VA
  • Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.
    Int J Surg Oncol Volume: 2012 Page(s): 524981
    01/01/2012 Authors: Cross BW; Johnson TV; Derosa AB; Ogan K; Pattaras JG; Nieh PT; Kucuk O; Harris WB; Master VA
  • A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the Prostate.
    Proc SPIE Int Soc Opt Eng Volume: 2012
    01/01/2012 Authors: Fei B; Schuster DM; Master V; Akbari H; Fenster A; Nieh P
  • Prostate cancer treatment ascertained from several sources: analysis of disagreement and error.
    Ann Oncol Volume: 23 Page(s): 256 - 263
    01/01/2012 Authors: Goodman M; Steenland NK; Almon ML; Liff JS; Dilorio CK; Butler SO; Ekwueme DU; Hall IJ; Smith JL; Master VA
  • C-reactive protein: a clinically useful biomarker in renal cell carcinoma.
    JAAPA Volume: 25 Page(s): 45 - 47
    01/01/2012 Authors: Johnson TV; DeLong J; Master VA
  • Prostate cancer treatment ascertained from several sources: analysis of disagreement and error.
    Ann Oncol Volume: 23 Page(s): 256 - 263
    01/01/2012 Authors: Goodman M; Steenland NK; Almon ML; Liff JS; Dilorio CK; Butler SO; Ekwueme DU; Hall IJ; Smith JL; Master VA
  • Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.
    Mol Imaging Biol Volume: 13 Page(s): 1272 - 1277
    12/01/2011 Authors: Savir-Baruch B; Schuster DM; Jarkas N; Master VA; Nieh PT; Halkar RK; Nye JA; Lewis MM; Crowe RJ; Voll RJ
  • Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
    J Urol Volume: 186 Page(s): 1213 - 1217
    10/01/2011 Authors: Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO
  • Increased mortality among Hispanic testis cancer patients independent of neighborhood socioeconomic status: a SEER study.
    J Immigr Minor Health Volume: 13 Page(s): 818 - 824
    10/01/2011 Authors: Johnson TV; Hsiao W; Jani A; Master VA
  • Review of the relationship between C-reactive protein and exercise.
    Mol Diagn Ther Volume: 15 Page(s): 265 - 275
    10/01/2011 Authors: Michigan A; Johnson TV; Master VA
  • International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma.
    Eur Urol Volume: 60 Page(s): 673 - 683
    10/01/2011 Authors: Margulis V; Master VA; Cost NG; Leibovich BC; Joniau S; Kuczyk M; Mulders PF; Kirkali Z; Wirth MP; Hirao Y
  • Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT.
    Clin Nucl Med Volume: 36 Page(s): 800 - 802
    09/01/2011 Authors: Amzat R; Taleghani P; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Lewis MM; Faurot M; Bellamy LM; Goodman MM
  • Intensive medical student involvement in short-term surgical trips provides safe and effective patient care: a case review.
    BMC Res Notes Volume: 4 Page(s): 317
    09/01/2011 Authors: Leeds IL; Creighton FX; Wheatley MA; Macleod JB; Srinivasan J; Chery MP; Master VA
  • Hidden variables: why patients may misunderstand written screening tools.
    JAAPA Volume: 24 Page(s): 38 - 40
    09/01/2011 Authors: Johnson TV; DeLong J; Master VA
  • Intra-tumor Doppler flow patterns do not predict malignancy of renal masses in a United States population.
    Can J Urol Volume: 18 Page(s): 5831 - 5835
    08/01/2011 Authors: Hsiao W; Shrewsberry AB; Moses KA; Malek-Jones M; Baumgarten D; Master VA; Ogan K
  • Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.
    Mol Diagn Ther Volume: 15 Page(s): 229 - 234
    08/01/2011 Authors: Michigan A; Johnson TV; Master VA
  • Pediatric adrenal trauma in the 21st century: Children's Hospital of Atlanta experience.
    J Urol Volume: 186 Page(s): 248 - 251
    07/01/2011 Authors: Figler BD; Webman R; Ramey C; Kaye J; Patrick E; Kirsch A; Smith E; Master VA
  • Learning from Haiti.
    Lancet Volume: 377 Page(s): 2054
    06/11/2011 Authors: Creighton FX; Leeds IL; Master VA; Srinivasan JK
  • Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
    Radiology Volume: 259 Page(s): 852 - 861
    06/01/2011 Authors: Schuster DM; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Rossi PJ; Lewis MM; Nye JA; Yu W; Bowman FD
  • Dynamic assessment of risk in clear cell renal cell carcinoma: The Emory Dynamic Model.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    05/20/2011 Authors: Harris W; Lingerfelt BM; Osunkoya AO; Master VA
  • Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    05/20/2011 Authors: Figlin RA; Nicolette CA; Amin A; Dudek A; Logan T; Lance RS; Holzbeierlein JM; Pal SK; Master VA; DeBenedette M
  • Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.
    J Clin Oncol Volume: 29 Page(s): 2532
    05/20/2011 Authors: Figlin RA; Nicolette CA; Amin A; Dudek A; Logan T; Lance RS; Holzbeierlein JM; Pal SK; Master VA; DeBenedette M
  • Dynamic assessment of risk in clear cell renal cell carcinoma: The Emory Dynamic Model.
    J Clin Oncol Volume: 29 Page(s): e15123
    05/20/2011 Authors: Harris W; Lingerfelt BM; Osunkoya AO; Master VA
  • Simple perioperative algorithm for serum C-reactive protein: A potent, independent, adverse prognostic factor for renal cell carcinoma
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Harris WB; Lingerfelt BM; Chen Z; Kucuk O; Osunkoya AO; Pattaras JG; Ogan K; Nieh PT; Petros JA; Young AN
  • Initial experience with videoscopic inguinal lymphadenectomy.
    Ann Surg Oncol Volume: 18 Page(s): 977 - 982
    04/01/2011 Authors: Delman KA; Kooby DA; Rizzo M; Ogan K; Master V
  • Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.
    Tumour Biol Volume: 32 Page(s): 375 - 380
    04/01/2011 Authors: Ali S; Yin-Goen Q; Johnson TV; Han W; Johnson NA; Harris WB; Marshall FF; Young AN; Master VA; Osunkoya AO
  • Medical student surgery elective in rural Haiti: a novel approach to satisfying clerkship requirements while providing surgical care to an underserved population.
    World J Surg Volume: 35 Page(s): 739 - 744
    04/01/2011 Authors: Chin-Quee A; White L; Leeds I; MacLeod J; Master VA
  • INTRATUMORAL C-REACTIVE PROTEIN AS A BIOMARKER OF PROGNOSIS IN LOCALIZED RENAL CELL CARCINOMA
    Volume: 185 Page(s): E667 - E668
    04/01/2011 Authors: Johnson T; Master V; Abbasi A; Kucuk O; Young A; Ogan K; Pattaras J; Nieh P; Marshall F; Osunkoya A
  • POSTERIOR LUMBAR VEIN OFF THE RETROHEPATIC INFERIOR VENA CAVA: A NOVEL ANATOMICAL VARIANT WITH SURGICAL IMPLICATIONS
    Volume: 185 Page(s): E708 - E709
    04/01/2011 Authors: Abbasi A; Johnson T; Kleris R; Ying K; Bonner M; Maithel S; Kooby D; Master V
  • EXTRAMAMMARY PAGET'S DISEASE IN MALES: A SEER STUDY IN SURVIVAL
    Volume: 185 Page(s): E240 - E240
    04/01/2011 Authors: Herrel LA; Johnson TV; Master VA; Delman KA
  • PROSPECTIVE STUDY OF SMOKING CESSATION IN PATIENTS UNDERGOING UROLOGIC SURGERY
    Volume: 185 Page(s): E23 - E23
    04/01/2011 Authors: Kunzel B; Cabalza J; Faurot M; Solomon T; Nieh P; Pattaras J; Master V; Ogan K
  • Extramammary Paget's disease of the penis and anogenital area: SEER analysis
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    03/01/2011 Authors: Master VA; Herrel L; Johnson TV; Delman KA
  • Use of preoperative erythrocyte sedimentation rate (ESR) to predict overall survival in localized renal cell carcinoma following radical nephrectomy
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    03/01/2011 Authors: Master VA; Kucuk O; Harris W; Cross B; Abbasi A; Michigan A; DeRosa A; Johnson TV; Marshall FF
  • Use of preoperative erythrocyte sedimentation rate (ESR) to predict overall survival in localized renal cell carcinoma following radical nephrectomy.
    J Clin Oncol Volume: 29 Page(s): 361
    03/01/2011 Authors: Master VA; Kucuk O; Harris W; Cross B; Abbasi A; Michigan A; DeRosa A; Johnson TV; Marshall FF
  • Extramammary Paget's disease of the penis and anogenital area: SEER analysis.
    J Clin Oncol Volume: 29 Page(s): 220
    03/01/2011 Authors: Master VA; Herrel L; Johnson TV; Delman KA
  • Minor symptoms are suggestive of metastatic renal cell carcinoma if c-reactive protein remains high after curative nephrectomy.
    J Clin Oncol Volume: 29 Page(s): e133 - e134
    02/20/2011 Authors: Abbasi A; Johnson TV; Master VA
  • Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma
    Volume: 91 Page(s): 176A - 176A
    02/01/2011 Authors: Ali S; Master VA; Abbasi A; Kucuk O; Young AN; Ogan K; Pattaras JG; Nieh PT; Marshall FF; Osunkoya AO
  • Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma.
    Volume: 24 Page(s): 176A - 176A
    02/01/2011 Authors: Ali S; Master VA; Abbasi A; Kucuk O; Young AN; Ogan K; Pattaras JG; Nieh PT; Marshall FF; Osunkoya AO
  • Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy.
    Pract Radiat Oncol Volume: 1 Page(s): 243 - 250
    01/01/2011 Authors: Shelton J; Rossi PJ; Chen H; Liu Y; Master VA; Jani AB
  • Automatic 3D Segmentation of Ultrasound Images Using Atlas Registration and Statistical Texture Prior.
    Volume: 7964
    01/01/2011 Authors: Yang X; Schuster D; Master V; Nieh P; Fenster A; Fei B
  • Nocturia associated with depressive symptoms.
    Urology Volume: 77 Page(s): 183 - 186
    01/01/2011 Authors: Johnson TV; Abbasi A; Ehrlich SS; Kleris RS; Raison CL; Master VA
  • C-reactive protein may represent sensitive measure of renal cell carcinoma metastasis.
    Urol Nurs Volume: 31 Page(s): 181 - 194
    01/01/2011 Authors: Johnson TV; Young AN; Force S; Master VA
  • A PET/CT Directed, 3D Ultrasound-Guided Biopsy System for Prostate Cancer.
    Volume: 6363 Page(s): 100 - 108
    01/01/2011 Authors: Fei B; Master V; Nieh P; Akbari H; Yang X; Fenster A; Schuster D
  • Urologic Trauma
    Page(s): 497 - 510
    01/01/2011 Authors: Figler BD; Master VA
  • Estimated volume growth characteristics of renal tumors undergoing active surveillance.
    Can J Urol Volume: 17 Page(s): 5459 - 5464
    12/01/2010 Authors: Hwang CK; Ogan K; Pattaras J; Master VA
  • Major depression drives severity of American Urological Association Symptom Index.
    Urology Volume: 76 Page(s): 1317 - 1320
    12/01/2010 Authors: Johnson TV; Abbasi A; Ehrlich SS; Kleris RS; Chirumamilla SL; Schoenberg ED; Owen-Smith A; Raison CL; Master VA
  • Decreased cancer survival in individuals separated at time of diagnosis: Critical period for cancer pathophysiology?
    Cancer Volume: 116 Page(s): 5564
    12/01/2010 Authors: Johnson TV; Master VA
  • Non-malignant drivers of elevated C-reactive protein levels differ in patients with and without a history of cancer.
    Mol Diagn Ther Volume: 14 Page(s): 295 - 303
    10/01/2010 Authors: Johnson TV; Master VA
  • Radical nephrectomy via epidural-only anesthesia.
    Can J Urol Volume: 17 Page(s): 5401 - 5402
    10/01/2010 Authors: Johnson TV; Bond N; Master VA
  • Multiple potential infectious causes of hematuria complicate this diagnosis. A diagnosis of schistosomiasis is made after four of five possible etiologies are ruled out, illustrating the need to test for all triggers before initiating treatment.
    JAAPA Volume: 23 Page(s): 26 - 32
    10/01/2010 Authors: Johnson TV; DeLong J; Master VA
  • Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.
    Urology Volume: 76 Page(s): 766.e1 - 766.e5
    09/01/2010 Authors: Johnson TV; Abbasi A; Owen-Smith A; Young AN; Kucuk O; Harris WB; Osunkoya AO; Ogan K; Pattaras J; Nieh PT
  • Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease.
    J Urol Volume: 184 Page(s): 512 - 518
    08/01/2010 Authors: Hsiao W; Moses KA; Goodman M; Jani AB; Rossi PJ; Master VA
  • The impact of income and education on dietary habits in stone formers.
    Urology Volume: 76 Page(s): 307 - 313
    08/01/2010 Authors: Saint-Elie DT; Patel PV; Healy KA; Solomon T; Pattaras JG; Qian J; Master VA; Ogan K
  • Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program.
    Cancer Volume: 116 Page(s): 2960 - 2966
    06/15/2010 Authors: Johnson TV; Hsiao W; Delman KA; Jani AB; Brawley OW; Master VA
  • C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma.
    Mol Diagn Ther Volume: 14 Page(s): 191 - 193
    06/01/2010 Authors: Johnson TV; Young AN; Osunkoya AO; Master VA
  • Report of a clinical trial of anti-1 amino 3 [18F]fluorocyclobutane-1-carboxylic acid (anti-[18F]FACBC) PET-CT in recurrent prostate carcinoma
    JOURNAL OF NUCLEAR MEDICINE Volume: 51
    05/01/2010 Authors: Schuster D; Savir-Baruch B; Nieh P; Master V; Halkar R; Rossi P; Lewis M; Yu W; Bowman F; Goodman M
  • Pilot evaluation of 1-amino-2-[18F]fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma
    Volume: 51
    05/01/2010 Authors: Savir-Baruch B; Schuster D; Jarkas N; Master V; Nieh P; Halkar R; Nye J; Lewis M; Roberts D; Goodman M
  • Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
    Am J Clin Oncol Volume: 33 Page(s): 168 - 172
    04/01/2010 Authors: Jani AB; Johnstone PAS; Liauw SL; Master VA; Rossi PJ
  • POSTOPERATIVE BETTER THAN PREOPERATIVE C-REACTIVE PROTEIN AT PREDICTING OUTCOME FOLLOWING POTENTIALLY CURATIVE NEPHRECTOMY FOR RENAL CELL CARCINOMA
    Volume: 183 Page(s): E198 - E198
    04/01/2010 Authors: Master V; Johnson T; Abbasi A; Owen-Smith A; Young A; Kucuk O; Harris W; Osunkoye A; Ogan K; Pattaras J
  • Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma.
    Ann Surg Oncol Volume: 17 Page(s): 731 - 737
    03/01/2010 Authors: Delman KA; Kooby DA; Ogan K; Hsiao W; Master V
  • Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
    J Clin Oncol Volume: 28 Page(s): 1069 - 1074
    02/20/2010 Authors: Moses KA; Paciorek AT; Penson DF; Carroll PR; Master VA
  • Growing Experience with Videoscopic Inguinal Lymphadenectomy (VIL): Moving Towards Better Outcomes
    Volume: 17 Page(s): S15 - S15
    02/01/2010 Authors: Delman KA; Kooby DA; Rizzo M; Ogan K; Maithel SK; Master V
  • Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    J Urol Volume: 183 Page(s): 480 - 485
    02/01/2010 Authors: Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
  • Expression of CRP and COX-2 in Clear Cell Renal Cell Carcinoma: Correlation with Pathological Parameters in 110 Patients
    Volume: 23 Page(s): 175A - 175A
    02/01/2010 Authors: Ali S; Young AN; Johnson TV; Yin-Goen Q; Johnson NA; Harris W; Master VA; Osunkoya AO
  • Expression of CRP and COX-2 in Clear Cell Renal Cell Carcinoma: Correlation with Pathological Parameters in 110 Patients
    Volume: 90 Page(s): 175A - 175A
    02/01/2010 Authors: Ali S; Young AN; Johnson TV; Yin-Goen Q; Johnson NA; Harris W; Master VA; Osunkoya AO
  • Body mass index as a predictor of urological disease and outcomes-overly simplistic?
    J Urol Volume: 183 Page(s): 427 - 429
    02/01/2010 Authors: Master VA
  • Impact of Prostate Motion on Delivered Dose during Intensity Modulated Radiotherapy
    Volume: 78 Page(s): S685 - S685
    01/01/2010 Authors: Schreibmann E; Shelton J; Rossi PJ; Master VA; Jani AB
  • Poorly numerate patients in an inner city hospital misunderstand the American Urological Association symptom score.
    Urology Volume: 75 Page(s): 148 - 152
    01/01/2010 Authors: Master VA; Johnson TV; Abbasi A; Ehrlich SS; Kleris RS; Abbasi S; Prater A; Owen-Smith A; Goodman M
  • Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique.
    Eur Urol Volume: 56 Page(s): 821 - 828
    11/01/2009 Authors: Master V; Ogan K; Kooby D; Hsiao W; Delman K
  • LEG ENDOSCOPIC GROIN LYMPHADENECTOMY FOR GENITOURINARY CANCER (LEG PROCEDURE)
    JOURNAL OF ENDOUROLOGY Volume: 23 Page(s): A53 - A53
    10/01/2009 Authors: Master V; Ogan K; Kooby D; Hsiao W; Delman K
  • Multimedia version of a standard medical questionnaire improves patient understanding across all literacy levels.
    J Urol Volume: 182 Page(s): 1120 - 1125
    09/01/2009 Authors: Bryant MD; Schoenberg ED; Johnson TV; Goodman M; Owen-Smith A; Master VA
  • Improper retrograde urethrogram technique leads to incorrect diagnosis.
    J Urol Volume: 182 Page(s): 716 - 717
    08/01/2009 Authors: Breyer BN; Cooperberg MR; McAninch JW; Master VA
  • Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity.
    Am J Clin Oncol Volume: 32 Page(s): 291 - 295
    06/01/2009 Authors: Jani AB; Fox TH; Blaustein D; Rossi PJ; Johnstone PA; Master VA
  • Effects of obesity and weight loss in patients with nononcological urological disease.
    J Urol Volume: 181 Page(s): 2424 - 2429
    06/01/2009 Authors: Natarajan V; Master V; Ogan K
  • Effect of obesity on urethroplasty outcome.
    Urology Volume: 73 Page(s): 1352 - 1355
    06/01/2009 Authors: Breyer BN; McAninch JW; Whitson JM; Eisenberg ML; Master VA; Voelzke BB; Elliott SP
  • Initial report of a clinical trial of anti-1 amino 3 [18F]fluorocyclobutane-1-carboxylic acid (anti-[18F] FACBC) PET-CT in recurrent prostate cancer
    JOURNAL OF NUCLEAR MEDICINE Volume: 50
    05/01/2009 Authors: Schuster D; Savir-Baruch B; Nieh P; Votaw J; Nye J; Master V; Halkar R; Bowman F; Goodman M
  • ENDOSCOPIC MODIFIED INGUINAL LYMPHADENECTOMY: LEG ENDOSCOPIC GROIN (LEG) PROCEDURE
    Volume: 181 Page(s): 605 - 606
    04/01/2009 Authors: Hsiao W; Herrel L; Delman KA; Ogan K; Master VA
  • IMPACT OF WEIGHT LOSS ON SEXUAL FUNCTION IN OBESE WOMEN
    Volume: 181 Page(s): 564 - 565
    04/01/2009 Authors: Saint-Elie DT; Healy KA; Williams J; Lin E; Davis SS; Ritenour CW; Pattaras JG; Master VA; Ogan K
  • Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
    Radiother Oncol Volume: 90 Page(s): 353 - 358
    03/01/2009 Authors: Rossi PJ; Schreibmann E; Jani AB; Master VA; Johnstone PAS
  • Combined nephrectomy and major hepatectomy: indications, outcomes, and recommendations.
    J Am Coll Surg Volume: 208 Page(s): 410 - 418
    03/01/2009 Authors: Yezhelyev M; Master V; Egnatashvili V; Kooby DA
  • Ureteropelvic junction disruption after blunt abdominal trauma.
    J Trauma Volume: 66 Page(s): 287
    01/01/2009 Authors: Subramanian A; Rozycki GS; Master V
  • Assessment of the performance of the American Urological Association symptom score in 2 distinct patient populations.
    J Urol Volume: 181 Page(s): 230 - 237
    01/01/2009 Authors: Johnson TV; Schoenberg ED; Abbasi A; Ehrlich SS; Kleris R; Owen-Smith A; Gunderson K; Master VA
  • MINIMIZING THE IMPACT OF WRITTEN SCREENING TOOLS ON THE MANAGEMENT OF ADULT PATIENTS WITH LOW HEALTH LITERACY
    Page(s): 49 - 55
    01/01/2009 Authors: Johnson TV; Master VA
  • Re: The efficacy of written screening tools in an inner city hospital: literacy based limitations on patient access to appropriate care T. V. Johnson, M. Goodman and V. A. Master J Urol 2007; 178: 623-629.
    J Urol Volume: 180 Page(s): 1573 - 1575
    10/01/2008 Authors: Robinson D; Johnson TV; Master VA
  • The efficacy of written screening tools in an inner city hospital: Literacy-based limitations on patient access to appropriate care
    Volume: 207 Page(s): S74 - S74
    09/01/2008 Authors: van Johnson T; Master VA; Goodman M
  • Can we count on written symptom scores: Impact of numeracy on patient access to appropriate healthcare
    Volume: 207 Page(s): S112 - S112
    09/01/2008 Authors: Johnson TV; Master VA; Abbasi A; Ehrlich SS; Kleris RS; Schoenberg ED; Owen-Smith A; Goodman M
  • Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
    Am J Clin Oncol Volume: 31 Page(s): 375 - 378
    08/01/2008 Authors: Jani AB; Johnstone PAS; Liauw SL; Master VA; Brawley OW
  • Penetrating external genital trauma: a 30-year single institution experience.
    J Urol Volume: 180 Page(s): 192 - 195
    07/01/2008 Authors: Phonsombat S; Master VA; McAninch JW
  • Active surveillance for the management of prostate cancer in a contemporary cohort.
    Cancer Volume: 112 Page(s): 2664 - 2670
    06/15/2008 Authors: Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA
  • Patient misunderstanding of the individual questions of the American Urological Association symptom score.
    J Urol Volume: 179 Page(s): 2291 - 2294
    06/01/2008 Authors: Johnson TV; Abbasi A; Ehrlich SS; Kleris RS; Schoenberg ED; Owen-Smith A; Goodman M; Master VA
  • Minimally invasive endovascular techniques to treat acute renal hemorrhage.
    J Urol Volume: 179 Page(s): 2248 - 2252
    06/01/2008 Authors: Breyer BN; McAninch JW; Elliott SP; Master VA
  • Impact of depression on perception of voiding symptoms
    Volume: 179 Page(s): 112 - 113
    04/01/2008 Authors: Master VA; Johnson TV; Abbasi AA; Ehrlich SS; Kleris RS; Chirumamilla SL; Schoenberg ED; Owen-Smith A; Raison CL
  • Stage IV prostate cancer: The effect of TNM staging and age of diagnosis on survival
    Volume: 179 Page(s): 113 - 114
    04/01/2008 Authors: Hsiao W; Zhou G; Goodman M; Master VA
  • Endovascular management of trauma related renal artery thrombosis.
    J Trauma Volume: 64 Page(s): 1123 - 1125
    04/01/2008 Authors: Breyer BN; Master VA; Marder SR; McAninch JW
  • Prostate cancer modality time trend analyses from 1973-2004: A surveillance, epidemiology, and end results (SEER) registry analysis
    Volume: 72 Page(s): S40 - S40
    01/01/2008 Authors: Jani AB; Johnstone PAS; Liauw S; Master V; Rossi PJ
  • Renal epithelial neoplasms: diagnostic applications of gene expression profiling.
    Adv Anat Pathol Volume: 15 Page(s): 28 - 38
    01/01/2008 Authors: Young AN; Master VA; Paner GP; Wang MD; Amin MB
  • Primary penile angiosarcoma in a patient with AIDS: a case report.
    AIDS Volume: 21 Page(s): 2355 - 2356
    11/12/2007 Authors: Moses KA; Tillett JW; Master VA
  • Applying population dynamics modeling to patients with lymph node positive prostate cancer.
    J Urol Volume: 178 Page(s): 1952 - 1955
    11/01/2007 Authors: Johnstone PAS; Riffenburgh RH; Rossi PJ; Assikis V; Master VA; Jani AB
  • The efficacy of written screening tools in an inner city hospital: literacy based limitations on patient access to appropriate care.
    J Urol Volume: 178 Page(s): 623 - 629
    08/01/2007 Authors: Johnson TV; Goodman M; Master VA
  • Race and disparities in health.
    Curr Probl Cancer Volume: 31 Page(s): 114 - 122
    01/01/2007 Authors: Brawley OW; Jani AB
  • Prostate cancer and race.
    Curr Probl Cancer Volume: 31 Page(s): 211 - 225
    01/01/2007 Authors: Brawley OW; Jani AB; Master V
  • Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry.
    Prostate Cancer Prostatic Dis Volume: 10 Page(s): 347 - 351
    01/01/2007 Authors: Jani AB; Master VA; Rossi PJ; Liauw SL; Johnstone PAS
  • 'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.
    Prostate Cancer Prostatic Dis Volume: 10 Page(s): 237 - 241
    01/01/2007 Authors: Johnstone PAS; Rossi PJ; Jani AB; Master V
  • Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.
    J Nucl Med Volume: 48 Page(s): 56 - 63
    01/01/2007 Authors: Schuster DM; Votaw JR; Nieh PT; Yu W; Nye JA; Master V; Bowman FD; Issa MM; Goodman MM
  • Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating pelvic lymph nodes in high-risk prostate cancer
    Volume: 69 Page(s): S354 - S355
    01/01/2007 Authors: Rossi PJ; Schreibmann E; Jani AB; Master VA; Johnstone PAS
  • Lack of survival benefit of post-operative radiation therapy in prostate cancer patients with positive lymph nodes.
    Prostate Cancer Prostatic Dis Volume: 10 Page(s): 185 - 188
    01/01/2007 Authors: Johnstone PAS; Assikis V; Goodman M; Ward KC; Riffenburgh RH; Master V
  • Current trends in the molecular classification of renal neoplasms.
    ScientificWorldJournal Volume: 6 Page(s): 2505 - 2518
    12/15/2006 Authors: Young AN; Master VA; Amin MB
  • Management of severe urethral complications of prostate cancer therapy.
    J Urol Volume: 176 Page(s): 2508 - 2513
    12/01/2006 Authors: Elliott SP; McAninch JW; Chi T; Doyle SM; Master VA
  • Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma.
    J Endourol Volume: 20 Page(s): 504 - 508
    07/01/2006 Authors: Eisenberg MS; Meng MV; Master VA; Stoller ML; Rini BI; Carroll PR; Kane CJ
  • Operative management of renal injuries: parenchymal and vascular.
    Urol Clin North Am Volume: 33 Page(s): 21 - vi
    02/01/2006 Authors: Master VA; McAninch JW
  • The independent impact of extended pattern biopsy on prostate cancer stage migration.
    J Urol Volume: 174 Page(s): 1789 - 1793
    11/01/2005 Authors: Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
  • Management of isolated renal fossa recurrence following radical nephrectomy.
    J Urol Volume: 174 Page(s): 473 - 477
    08/01/2005 Authors: Master VA; Gottschalk AR; Kane C; Carroll PR
  • Appropriate use of CT in the diagnosis of bladder rupture.
    J Am Coll Surg Volume: 200 Page(s): 973
    06/01/2005 Authors: Doyle SM; Master VA; McAninch JW
  • Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities.
    J Urol Volume: 172 Page(s): 2197 - 2202
    12/01/2004 Authors: Master VA; Shinohara K; Carroll PR
  • Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy.
    J Urol Volume: 172 Page(s): 2287 - 2291
    12/01/2004 Authors: Anast JW; Stoller ML; Meng MV; Master VA; Mitchell JA; Bassett WW; Kane CJ
  • Safety and effectiveness of a new saline filled testicular prosthesis.
    J Urol Volume: 172 Page(s): 1427 - 1430
    10/01/2004 Authors: Turek PJ; Master VA; Testicular Prosthesis Study Group
  • Gastric duplication cyst causing gastric outlet obstruction.
    Pediatr Radiol Volume: 34 Page(s): 574 - 576
    07/01/2004 Authors: Master V; Woods RH; Morris LL; Freeman J
  • Intermediate results of ferromagnetic thermal ablation for radiation failure local recurrence of prostate cancer
    Volume: 71 Page(s): S89 - S90
    05/01/2004 Authors: Shinohara K; Master V; Carroll P; McLeod D; Beyer D
  • Treatment and outcome of invasive bladder cancer in patients after renal transplantation.
    J Urol Volume: 171 Page(s): 1085 - 1088
    03/01/2004 Authors: Master VA; Meng MV; Grossfeld GD; Koppie TM; Hirose R; Carroll PR
  • An American hijra: a report of a case of genital self-mutilation to become India's "third sex".
    Urology Volume: 62 Page(s): 1121
    12/01/2003 Authors: Master V; Santucci R
  • Urothlelium facilitates the recruitment and trans-differentiation of fibroblasts into smooth muscle in acellular matrix.
    J Urol Volume: 170 Page(s): 1628 - 1632
    10/01/2003 Authors: Master VA; Wei G; Liu W; Baskin LS
  • Health related quality of life significance of single pad urinary incontinence following radical prostatectomy.
    J Urol Volume: 170 Page(s): 512 - 515
    08/01/2003 Authors: Cooperberg MR; Master VA; Carroll PR
  • Grade V renal injury: avulsion of the renal pedicle.
    J Am Coll Surg Volume: 195 Page(s): 425
    09/01/2002 Authors: Master VA; Franks J; McAninch JW
  • Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization.
    J Urol Volume: 167 Page(s): 2521 - 2522
    06/01/2002 Authors: Master VA; Meng MV; Koppie TM; Carroll PR; Grossfeld GD
  • Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection.
    J Clin Oncol Volume: 20 Page(s): 930 - 936
    02/15/2002 Authors: Damani MN; Master V; Meng MV; Burgess C; Turek P; Oates RD
  • Ejaculatory physiology and dysfunction.
    Urol Clin North Am Volume: 28 Page(s): 363 - x
    05/01/2001 Authors: Master VA; Turek PJ
  • Genital self-mutilation and the Internet.
    J Urol Volume: 164 Page(s): 1656
    11/01/2000 Authors: Master VA; McAninch JW; Santucci RA
  • Conserved anterior boundaries of Hox gene expression in the central nervous system of the leech Helobdella.
    Dev Biol Volume: 190 Page(s): 284 - 300
    10/15/1997 Authors: Kourakis MJ; Master VA; Lokhorst DK; Nardelli-Haefliger D; Wedeen CJ; Martindale MQ; Shankland M
  • Evolutionary conservation of Hox gene expression in the CNS of the leech Helobdella
    Volume: 186 Page(s): B98 - B98
    06/15/1997 Authors: Kourakis MJ; Master VA; Lokhorst DK; NardelliHaefliger D; Wedeen CJ; Martindale MQ; Shankland M
  • Homeobox genes in the Ctenophora: identification of paired-type and Hox homologues in the atentaculate ctenophore, Bero ovata.
    Mol Mar Biol Biotechnol Volume: 5 Page(s): 249 - 258
    12/01/1996 Authors: Finnerty JR; Master VA; Irvine S; Kourakis MJ; Warriner S; Martindale MQ
  • Isolation, characterization, and expression of Le-msx, a maternally expressed member of the msx gene family from the glossiphoniid leech, Helobdella.
    Dev Dyn Volume: 207 Page(s): 404 - 419
    12/01/1996 Authors: Master VA; Kourakis MJ; Martindale MQ
  • HOM/Hox gene duplication in the annelid leech Helobdella
    Volume: 175 Page(s): 1 - 1
    05/01/1996 Authors: Kourakis MJ; Master VA; Martindale MQ
  • IDENTIFICATION OF THE PREVIOUSLY UNIDENTIFIED HOMEOBOX-CONTAINING GENES, LOX-18-21, EXPRESSED IN LEECH EMBRYOS
    Volume: 163 Page(s): 546 - 546
    06/01/1994 Authors: MASTER VA; KOURAKIS MJ; MARTINDALE MQ
  • LOX11 A NOVEL LEECH HOMEOBOX-CONTAINING GENE WITH SEQUENCE SIMILARITY TO MSH AND MSX1, IS EXPRESSED DURING EARLY EMBRYOGENESIS
    Volume: 163 Page(s): 546 - 546
    06/01/1994 Authors: KOURAKIS MJ; MASTER VA; MARTINDALE MQ
  • Clinicopathologic Analysis of 53 Cases of Renal Cell Carcinoma With Vena Caval Involvement

    Authors: Nwadei I; Lorentz A; Master V; Osunkoya A
  • A Clinicopathologic Analysis of 53 Cases of Renal Cell Carcinoma With Vena Caval Involvement

    Authors: Nwadei I; Lorentz A; Master V; Osunkoya A
  • Utility of preoperative inflammatory markers for prognosis in patients with renal cell carcinoma and vena cava tumor thrombus

    Authors: Lorentz CA; Jafri SMA; Tai CG; Herrel LA; Master VA
  • Genomic Mapping of Primary Unifocal and Multifocal Renal Cell Carcinoma

    Authors: Obeng RC; Lorentz A; Alqassab U; Laganosky D; Keith C; Lian F; Ogan K; Master VA; Pattaras JG; Rossi M
  • Genomic Mapping of Primary Unifocal and Multifocal Renal Cell Carcinoma

    Authors: Obeng RC; Lorentz A; Alqassab U; Laganosky D; Keith C; Lian F; Ogan K; Master VA; Pattaras JG; Rossi M
  • NOMOGRAM TO PREDICT RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS USING A MULTI-CENTER CONTEMPORARY SERIES

    Authors: Blute ML; Masterson TA; Master VA; Margulis V; Lorentz CA; Bauman TM; Karam JA; Wood CG; Abel EJ
  • MULTICENTER VALIDATION OF PREDICTIVE MODEL FOR POSTSURGICAL RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS

    Authors: Blute ML; Masterson TA; Master VA; Margulis V; Lorentz A; Bauman T; Zorn K; Karam JA; Wood CG; Abel EJ
  • THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC)

    Authors: Pak JS; Lascano D; Finkelstein JB; McKiernan JM; DeCastro GJ; Capitanio U; Carballido JA; Chantada V; Chromecki T; Ciancio G
  • CANCER-SPECIFIC SURVIVAL AND PREDICTORS IN PATIENTS WITH CT3B KIDNEY CANCER: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM

    Authors: Linares E; Martinez-Salamanca JI; Novara G; Bertini R; Carballido J; Chromecki T; Ciancio G; Daneshmand S; Evans C; Gontero P
  • DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS

    Authors: Hao N; Tilki D; Dall'Era M; Bertini R; Carballido J; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J
  • IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS

    Authors: Rodriguez Faba O; Martinez Salamanca JI; Tilki D; Dall'Era MA; Nguyen HG; Roberto B; Carballido JA; Chromecki T; Ciancio G; Daneshmand S
  • LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM

    Authors: Martinez-Salamanca JI; Novara G; Bertini R; Carballido J; Chromecki T; Ciancio G; Daneshmand S; Evans C; Gontero P; Gonzalez J
  • IMPACT OF HISTOLOGIC SUBTYPE ON TUMOR THROMBUS LEVEL AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS

    Authors: Tilki D; Dall'Era MA; Nguyen HG; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements